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ABSTRACT 
The transcription factor NF-κB is a regulator of a wide variety of processes including 
inflammation, innate and adaptive immunity, apoptosis, and learning.  How can one factor be 
accurately involved in so many different processes and generate without exception precise and 
appropriate responses?  Four members of the NF-κB transcription factor family are involved in 
gene activation, and they hetero- or homodimerize with each other to bind DNA.  This allows for 
many different potential combinations of NF-κB dimers.  To test whether NF-κB-dependent genes 
require specific NF-κB family members for gene activation, cell lines were generated lacking in 
individual and multiple NF-κB proteins.  Using TNFα as an inducer, a panel of endogenous NF-
κB responsive genes showed a wide range of subunit specificities. Given that the NF-κB consensus 
binding site sequence is very broad and that crystal structures of NF-κB have not identified enough 
dimer-specific DNA-binding contacts to rationalize specific NF-κB binding sites, κB sites were 
compared from a single gene to another and no direct correlation was found between κb site 
sequence and κB family member requirements.  However when interspecies comparisons were 
made of the same gene, a remarkable constancy of the κB site sequence was found, which 
suggested that individual sites have important functional characteristics.  To test this theory, a 
novel lentiviral system was created that incorporated regulatory sequences into cellular DNA.  
Then by simply swapping sites between κB-dependent genes, NF-κB dimer specificity of the 
promoters was altered and revealed that two κB sites can function together as a module to regulate 
gene activation.  Further, although the sequence of the κB site is important for determining κB 
family member specificity, rather than determining the ability of a particular dimer to bind 
effectively, the sequence affects which co-activators will form productive interactions with the 
bound κB dimer.  My findings suggest that a particular DNA-binding site may impart a specific 
configuration to bound transcription factors that specifies the requirement for particular co-
activators.  Taken together, I have taken the first steps to dissecting how the promoter code 
influences individual NF-κB family members to function on NF-κB responsive genes and to 
regulate gene expression. 
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CHAPTER 1: INTRODUCTION 
Transcription Specificity 
In mammalian cells, signaling molecules such as transcription factors are often encoded into gene 
families where members have distinct and overlapping functions.  However, little is known about 
how individual family members within a particular transcription factor family operate.  Study of 
this aspect of transcription control is often confounded by the recognition of a single regulatory 
sequence by multiple members of a transcription factor family.  For example, in vitro studies have 
shown that all members of the basic helix-loop-helix (bHLH) leucine zipper transcription factor 
family recognize the same DNA-binding motif.  While this result may be interpreted as functional 
redundancy among bHLH transcription factors, in vivo studies have demonstrated discrimination 
among particular family members at a particular site (Mai S., 1995).  The fact that increasingly 
complex genomes contain a greater number of gene family members rather than novel families 
(Lander et al., 2001) suggests that diversity within a gene family may provide for specificity and 
versatility in the regulation of cellular responses.  Characterizing the specific functions of 
individual members of transcription factor gene families contributes to our understanding of gene 
regulatory networks and to the development of specific therapeutic strategies. 
 
The best understood example of transcription specificity is the nuclear hormone receptor (NHR) 
family, where individual members within the family have different intrinsic in vivo DNA-binding 
specificities. NHR family members bind two tandem cognate DNA half-sites, and biochemical 
studies have shown that the spacing between the two half-sites determines which NHR family 
members bind and function (Rastinejad, 2001).  For example, thyroid hormone receptor binds to 
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DNA when four nucleotides separate the half-sites, whereas retinoic acid hormone receptor binds 
when the half-sites are separated by two nucleotides.  This principle implies that adding or 
subtracting a number of nucleotides between the two DNA half-sites can alter a gene’s 
responsiveness to a particular nuclear hormone receptor. Taken together, this evidence shows that 
the sequence of the NHR DNA-binding sites determines which family members bind and function.  
Recent structural studies with the glucocorticoid receptor (GR), a member of the NHR family, 
demonstrated that the DNA-binding domain of GR binds its cognate site in a variety of 
conformations depending on the sequence of the site (Lefstin and Yamamoto, 1998).  The bound 
conformation served to present different interfaces for the recruitment of specific co-factors and to 
help determine whether the bound factor will activate or repress transcription.  Further work has 
shown which GR surfaces are required in a gene-specific manner (Rogatsky et al., 2002; Rogatsky 
et al., 2003). Similar findings have also been reported for the POU family of proteins (Phillips and 
Luisi, 2000). 
 
However, for many other transcription factor families, such as the C/EBP (Ramji and Foka, 2002), 
E2F (Trimarchi and Lees, 2002), AP-1 (Chinenov and Kerppola, 2001; Mechta-Grigoriou et al., 
2001), and NF-κB families, marked DNA-binding specificity rules have not been identified.  
Indeed, the raison d’être of multiple members within signal transduction protein families may not 
be molecular interaction specificities but could be found in their own differential regulation. 
 
Nuclear Factor kappa B (NF-κB) 
NF-κB is a dimeric protein that mediates cellular responses to a wide variety of stimuli including 
TNFα, LPS, IL-1, and ultraviolet light (Ghosh et al., 1998; Karin and Ben-Neriah, 2000; Karin et 
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al., 2002).  When our lab discovered this factor in 1986, NF-κB was thought to be involved in the 
control of the κ immunoglobulin locus in B cells (thus the name Nuclear Factor for κ in B cells).  
This assumption was quickly falsified when NF-κB was found to be widely expressed in many cell 
types and to be activated by a variety of stimuli.  The list of systems that require NF-κB to function 
correctly has grown to encompass a large portion of biology, including inflammatory responses, 
immune system development, apoptosis, learning in the brain, and bone development. In resting 
cells, NF-κB is held inactive via associations with inhibitory proteins called inhibitors of NF-κB 
(IκB). When the cell is stimulated, IκB proteins are phosphorylated, ubiquitinated, and degraded, 
allowing NF-κB to bind DNA and activate appropriate target genes.   
 
In response to inflammatory stimuli, four members of the NF-κB family are involved in gene 
activation: p50, p52, p65, and cRel. They are the mature gene products from four genes: nfκB1, 
nfκB2, relA, and cRel respectively, and they homo- or heterodimerize with one another to bind 
DNA.  The cognate DNA-binding element, the κB-site, is found in the promoters of NF-κB 
responsive genes but displays a remarkably loose consensus, often described as G-5G-4G-3R-2N-
1N0Y+1Y+1C+2C+3 (Chen et al., 1998a).  The heterogeneity of κB-sites has been thought to confer 
specificity of regulation mediated by differential affinities of NF-κB isoforms.  Purified 
recombinant RHD protein dimers could indeed be shown to select differential optimal DNA-
binding motifs from a pool of random oligonucleotides (Kunsch et al., 1992).  Similarly, one study 
with transfected promoter-reporter constructs showed that multimerized κB-sites from one of three 
different promoters (Igκ, MHC H2, and IFN-ß) exhibited differential responses when co-
transfected with p50 and/or p65 expression plasmids (Fujita et al., 1992).   
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Structural studies have also not revealed evidence for highly specific interactions between NF-κB 
and its cognate DNA-binding sites.  Crystal structures have shown that p50 homodimers often 
interact specifically with 5’-G-5G-4G-3, while p65 homodimers interact specifically with 5’-G-5G-4. 
X-ray structures of p50:p65 heterodimers demonstrate that they can bind to a variety of κB site 
sequences (Berkowitz et al., 2002; Chen and Ghosh, 1999; Chen-Park et al., 2002; Escalante et al., 
2002). Taken together, structural studies have not identified enough dimer-specific DNA-binding 
contacts to rationalize specific NF-κB binding sites and underscore the remarkable permissiveness 
in NF-κB-DNA interactions. 
 
Despite the difficulty in discerning specificity at the level of DNA-protein interactions, mice 
deficient in a single RHD protein show specific phenotypes.  rela-/- animals are embryonic lethal 
with massive hepatocyte apoptosis (Beg et al., 1995), while crel-/- mice develop normally but have 
defects in lymphocyte proliferation (Kontgen et al., 1995).  In part, family member-specific 
functions can be inferred by tissue specific expression.  While p65 appears to be ubiquitous, cRel is 
expressed constitutively in mature monocytic and lymphocytic lineages (Liou et al., 1994) and 
induced in other cell types, such as fibroblasts (Grumont and Gerondakis, 1990).  In addition, there 
are differences in the molecular characteristics of RHD family members: transfection studies have 
identified activation domains in p65 and cRel, but not in p50 and p52 (Chen et al., 1998a).  DNA-
binding assays were used to identify dimerization rules: p50 (and presumably p52) can partner 
with all RHD family members including themselves, while RelB and cRel do not appear to engage 
in homotypic interactions.  RelB, furthermore, does not appear to dimerize with p65 or cRel.  Little 
is known about how the results from in vitro biochemical characterizations of RHD proteins can 
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serve to explain physiologically relevant functional specificity in gene regulation, because 
selectivity of endogenous κB-site containing promoters remains largely unexplored.  In fact, in the 
case of the IL-12 promoter, results from cell-free or extra-chromosomal templates are shown not to 
recapitulate endogenous promoter specificity (Sanjabi et al., 2000). 
 
Genetic approaches are suitable to address questions of in vivo mechanistic specificity, but must 
take into account the possibility of interdependent regulation of factors in mammalian signaling 
networks; resulting compensatory mechanisms among functionally related molecules may lend 
increased robustness to signaling systems and affect the phenotype of genetic deletions. 
 
Overview of Thesis 
The overall question driving force of this thesis is “how does one transcription factor control so 
many different processes without generating inappropriate responses in particular settings?”  While 
NF-κB has been shown to be an important pillar in modulating cellular behavior in response to 
varied needs of organismal life, we know very little mechanistically of its functions.  
Understanding how NF-κB is regulated, how it interacts with other signaling pathways or 
molecules, and how it behaves on gene promoters will aid in understanding disease processes and 
aid in future drug design.  Right now, the first generation drugs that target NF-κB activities are 
being employed for osteoporosis, cancer, arthritis and sepsis.  Deeper knowledge of this key 
system will facilitate the creation of more specific drugs and therapies. 
 
With this framework established, we decided to look at the DNA level for answers.  Before I begin 
on my own work, Chapter 2 is an optional read for someone interested in the history of the field.  
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There are plenty of good books on the topic, but I felt it is important for me to write about it and to 
show how my work is placed in the general context of the field.  Chapter 3 describes how I 
collaborated with Alexander Hoffmann to create a genetic system to address whether NF-κB-
dependent genes require particular κB family members for activation.  Using 3T3 cell lines lacking 
individual and multiple NF-κB proteins and TNFα as an inducer, I found that a panel of 
endogenous NF-κB-dependent genes showed a wide range of subunit requirements.  After 
establishing that transcription specificity occurs in the NF-κB family, I wanted to address how 
specificity is determined and maintained.  Chapter 4 summarizes our studies where I found that the 
sequence of the κB binding site was important for determining family member specificity.  
However rather than determining the ability of a particular dimer to bind effectively, the sequence 
affects which co-activators will form productive interactions with the bound κB dimer.  Finally in 
Chapter 5, future studies are considered. 
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CHAPTER 2: A BRIEF HISTORY OF GENE REGULATION 
Regulation of gene transcription is an important mechanism conserved from bacteria to humans.  
In bacteria, gene control predominantly serves to adjust a cell’s response to changes in the 
environment.  In multicellular organisms, changes in the environment also alter gene expression.  
However, the most complex example of multicellular gene control is embryogenesis, where 
multiple cell types work flawlessly together to execute multiple genetic programs.  
 
The birth of modern biochemistry undoubtedly facilitated initial discoveries with respect to 
transcription control.  Early biochemical studies demonstrated that the same enzymes and 
pathways in yeast and mammalian cells were responsible for the conversion of glycogen to lactic 
acid.  This and other discoveries made it clear that core biological mechanisms and molecules are 
preserved over evolutionary times.  This has also been proven to hold true for transcription control.  
The concepts of promoters, allosteric regulation, and cooperative binding originally identified in 
bacteria by Monod, Jacob, and Lwoff are also important in yeast and higher eukaryotes.  
Eukaryotic cells are more complex than bacteria, and studies by Ptashne and Chambon have 
enumerated on these original findings and added the ideas of modular transcription factors, 
nucleosome, and enhancers.  More recent studies in higher eukaryotes by Maniatis and Chambon 
led to the concept of the enhanceosome.  The field of gene transcription has had a rich history filled 
with people of great stature, and this chapter highlights the important advances in transcription 
regulation with a particular focus on activators and repressors.  Information concerning the history 
and identification of the basal transcriptional machinery itself (for example TBP, TAFs, mediator 
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complex, nucleosome modifiers) has been consciously omitted, because my thesis work mainly 
concerns activators and the molecules they recruit.  
 
Lessons from Bacteria:  lacZ and the lambda repressor 
The enzyme ß-galactosidase, the product of the lacZ, is the first enzyme to act in bacterial 
metabolism of lactose.  The gene is fully activated when bacteria are grown in glucose-deficient, 
lactose-containing bacterial medium.  Glucose is an efficient energy source for bacteria and 
normally overrides lactose metabolism.  How does this regulation operate?  Two DNA-binding 
proteins control lacZ regulation: CAP (Catabolite Activator Protein) and the lac-Repressor.  In the 
absence of lactose and irrespective of the absence or presence of glucose, lac-Repressor binds its 
DNA-binding-site located in the operator region within the lac operon.  The presence of lac-
Repressor prevents RNA polymerase from binding to the lac operon.  In the absence of glucose, 
the CAP protein (also known as CRP or cAMP Receptor Protein) binds the lacZ operator and 
recruits RNA polymerase to the gene.  When glucose and lactose are both present, lac-Repressor is 
removed, but the absence of CAP prevents direct RNA polymerase recruitment and transcription is 
not induced.  Levels of lacZ transcript are marginally higher than resting levels, because RNA 
polymerase can randomly bind its exposed operator site.  When both glucose and lactose are 
absent, CAP and lac-Repressor are bound to their respective sites on the lac operon; lac-Repressor 
still prevents RNA polymerase binding and transcription is repressed. 
 
CAP and lac-Repressor are activated by their physiologic signals in an allosteric fashion.  In the 
absence of glucose, bacterial cells synthesize more cAMP protein.  cAMP binds and changes 
CAP’s (hence the original cAMP Receptor Protein or CRP designation) conformation, such that 
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CAP binds DNA more efficiently.  lac-Repressor undergoes a similar method of regulation.  In the 
presence of lactose, allolactose (a product of lactose breakdown) binds and changes lac-
Repressor’s conformation such that lac-Repressor no longer binds DNA. 
 
It is remarkable that Monod and Jacob were able to piece together the principles of this switch 
using genetics and bacterial conjugation.  Monod made the observation that the growth curve of E. 
coli differed depending on the presence of different carbohydrate pairs in the medium.  He believed 
that this was due to “enzyme adaptation” and devoted his life to the study of this phenomenon.  He 
established the ß-galactosidase system, understood that bacterial growth in that system was 
dependent on the synthesis of an astable enzyme, and isolated mutants which revealed that several 
key proteins were dependent on different genetic elements yet subjected to the same induction 
determinism and constitutive mutations.  Concurrently, Jacob had been studying bacterial 
conjugation and discovered that conjugation passed along the male chromosome without the male 
cytoplasm into the female bacterium.  Further, he developed a system to monitor kinetics of 
conjugation (limiting how much of the chromosome is transferred by using a kitchen blender) and 
another system of making “diploid” bacterium.  Jacob and Monod could now perform what we call 
now–reconstitution or rescue experiments.  Mutant bacteria could be injected with wild-type copies 
of genes to see if function is “rescued.”  For example, bacteria that produced ß-galactosidase 
constitutively were reconstituted with the genes for CAP or lacZ Repressor.  From the CAP protein 
reconstitution, induction of the introduced gene occurred at the maximum rate from the beginning 
(this finding led to the basis of the messenger RNA theory by Jacob).  The lac-Repressor 
reconstitution showed that the gene was dominant to the constitutive mutation but that this 
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dominance occurred in a slow plodding fashion.  This experiment was the basis for the “repressor” 
theory.   
 
Other work demonstrated CAP’s function to recruit RNA polymerase to the lacZ promoter.  
DNAse1 footprinting experiments showed that RNA polymerase bound to the lacZ promoter much 
more reliably in the presence of CAP.  CAP mutants were also identified that could bind the lacZ 
promoter, but RNA polymerase recruitment was absent and transcription was inhibited.  The 
region identified by the CAP mutant experiments interacted with the -subunit of bacterial RNA 
polymerase. -subunit RNA polymerase mutants were identified that could not activate lacZ in the 
presence of wildtype CAP protein.   
 
However, the most compelling proof of regulated recruitment was provided by three activator-
bypass experiments or experiments designed to bring RNA polymerase to the promoter in an 
alternative fashion.  The first used synthetic heterologous protein:protein interactions.  The DNA-
binding-domain of CAP was fused to a synthetic interacting protein.  The synthetic interacting 
protein’s partner was fused to RNA polymerase.  Expression of both mutant proteins activated lacz 
transcription.  Presumably, the synthetic interacting protein directed itself to the lacZ promoter via 
CAP’s DNA-binding-domain and recruited its partner to the same location.  The presence of RNA 
polymerase stimulated transcription of the reporter gene.  The second method involved fusing 
CAP’s DNA-binding-domain directly to RNA polymerase to entirely bypass the requirement for 
CAP. Expression of this mutant polymerase activated transcription of lacZ in the presence or 
absence of CAP protein.  The third experiment simply increased the amount of polymerase protein 
in the cell.  If CAP’s main function was to recruit RNA polymerase to particular genes, increasing 
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the concentration of free RNA polymerase would bypass the need for CAP.  Together, these 
experiments provide compelling evidence that CAP’s main function is to recruit RNA polymerase 
to the lacZ operon.   
 
In recent years, attention has been put on a molecular view of lacZ regulation.  Crystal structures of 
lac-Repressor bound to operator and inducer have identified the regions within lac-Repressor 
responsible for interaction.  Recently, Kalodimos and colleagues solved the remaining piece of the 
puzzle, a crystal structure of lac-Repressor bound to nonspecific DNA that has proved most 
insightful.  Interactions between transcription factors and nonspecific DNA are important in 
several ways.  1.  Nonspecific sites participate in the regulation of physiological function, because 
transcription factors are often complexed with them in vivo when not bound at their regulatory 
sites.  2. When nonspecific DNA-binding is allowed, it has been shown that the binding kinetics 
for transcription factors occur much faster than the kinetics based on simple diffusion.  Different 
mechanisms have been suggested to reconcile this difference that all depend on “facilitated 
transfer.” 3.  Even though a transcription factor binds its own binding site with high affinity, it also 
binds nonspecific sites with appreciable and significant affinity.  For example, lac-Repressor binds 
the operator at 108-fold stronger than binding at a nonspecific site, but there are 107 potential 
nonspecific binding sites in the E. coli genome.  
 
The crystal structure showed that lac-Repressor bound to nonspecific DNA is tilted by some 25 
angstroms compared to the repressor-operator complex.  As a result, the residues identified by the 
specific repressor-operator complex to interact directly with base pairs in the major groove of the 
operator are shifted.  Instead, the residues participate in hydrogen bonds or electrostatic 
 14
  
interactions with the phosphate groups of nonspecific DNA.  Mutating these residues lowers the 
affinity of repressor for operator some 100-fold and also lowers affinity for nonspecific DNA by 
10-fold.  These results highlight the dual-roles for the recognition region of lac-Repressor.  The 
region confers specificity when bound to the operator; at the same time, the region stabilizes lac-
Repressor when bound to nonspecific DNA.  Further, when lac-Repressor binds to operator, a 
hinge region that is speculated to play a major role in induction, transitions from a disordered state 
into an alpha helix.  When lac-Repressor binds nonspecific DNA, the hinge region remains in a 
disordered state. Finally, conformation studies performed in biologically relevant time showed that 
lac-Repressor is extremely flexible, open and variable on nonspecific DNA but adopts a more rigid 
structure when bound to operator.  In summary, this is all evidence for a structural switch within 
the lac-Repressor that directs the binding mode depending on the sequence of DNA.   
 
References:  (Berg et al., 1981; Jacob, 1972; Kalodimos et al., 2004; Lewis et al., 1996; Monod, 
1972; Ptashne and Gann, 2002) 
 
Lambda Phage 
Down the hall at the Institute Pasteur where the lacZ experiments were first being performed, 
Andre Lwoff and his group were studying lambda phage.  They noticed that when infected 
Escherichia coli were irradiated with ultraviolet light for 45 minutes, bacteria stopped growing and 
roughly 90 minutes later they lysed, spewing a crop of viruses called phage (or bacteriophages or 
bacteria-eaters) into the medium.  The newly released phage can then infect more bacteria and 
multiply within them.  Growth of phage follows two forms: lysogenic and lytic.  During lysogeny, 
lamba phage is integrated into the genome, and transcription of its own genome is kept to a 
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minimum. (Lwoff could passage lysogenically-infected bacteria over 19 generations without lysis.) 
During lytic growth, lambda phage is tremendously active, replicating furiously until endolysin is 
synthesized and the host cell is lysed releasing phage into the medium.  Initially, Lwoff planned to 
study lysogeny and how the prophage interacts with the host machinery but with these findings 
induction became his focus. 
 
The main principles learned from lacZ apply here, although the lambda switch is a bit more 
complex.  Within the OR operon, a central operator region composed of three binding sites, OR1, 
OR2, and OR3, plays the prominent role.  During lysogeny, lamba repressor protein binds to the 
OR1 and OR2 regions.  This forces RNA polymerase to bind OR3 and to transcribe the cI gene.  cI’s 
gene product is the lambda repressor protein itself, therefore this is a feed-forward regulation loop 
(analogous to lacZ). Until the appropriate inductive signal occurs, this mechanism ensures that the 
lysogenic growth cycle of the lambda phage is maintained.  UV light triggers lambda phage to 
enter its lytic growth cycle by activating RecA, a protein that promotes lambda repressor’s 
autodigestion.  The absence of lambda repressor on the operator reveals the OR1 and OR2 binding 
sites. OR1 and OR2 are inherently better binding sites than OR3 for RNA polymerase.  RNA 
polymerase binds to both sites and transcribes the cro genes in the opposite direction.  Cro gene 
products facilitate the lytic cycle.  By directing transcription away from cI, this elegant regulatory 
“switch” effectively shuts off the lysogenic growth cycle.  
 
How does lysogeny ever become established?  During the initial infection, cII protein is 
synthesized and binds a promoter site downstream of the cro genes.  The presence of cII recruits 
RNA polymerase to the promoter and stimulates transcription in the opposite direction of cro and 
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actually promotes synthesis of lambda repressor.  This allows lambda repressor levels to be 
established and entry into the lysogenic growth cycle.  Whether phage establishes lysogeny or lytic 
growth upon initial infection is dependent on a host protease that attacks cII protein.  If the cell is 
active and dividing, levels of the protease are high, cII protein is degraded, and phage enters the 
lytic growth cycle.  If the cell is inactive, levels of the protease are low, cII protein is stable, and 
phage enters the lysogenic growth cycle. 
 
Cooperativity plays a key role in the control of lambda repressor.   A repressor dimer binding OR1 
helps another dimer bind the adjacent weak site OR2.   While this cooperativity does not continue 
to the OR3 binding site, repressor may bind the OR3 site and turn off transcription of its own gene.  
This autoregulatory behavior is consistent with the requirements of an efficient switch, because 
free unbound repressor would bind inappropriately during activating conditions.  Because lambda 
repressor’s affinity for the OR3 binding site is lower than its affinity for OR1 or OR2, lambda 
repressor is able to regulate its own levels.  
 
Current work 
The activities of the repressor up to this point were identified by studying the OR region in 
isolation from the rest of the lambda phage chromosome.  This approach was clearly fruitful, 
because investigators were able to identify individual components important in regulation.  
However, studies with the whole lambda chromosome have helped scientists to reformulate some 
of the original conclusions and demonstrate that the switch works even more efficiently than had 
originally been thought.  
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Recent studies have identified a second operator OL positioned 2.4kB away from the OR operator. 
OL controls a different set of lambda phage genes and is similar to OR in structure and function. OL 
has three repressor binding sites OL1, OL2, and OL3, with OL1 also having the highest affinity.  
Repressor dimers bind OL1 and OL2 cooperatively, and repressor bound to OL3 turns off 
transcription of the adjacent promoter (PL).   Previously, repressor was shown to form dimers and 
tetramers on OR.  On a DNA molecule containing OR and OL, repressor binds to OR1, OR2, OL1, 
and OL2 to form an octomer (or four dimers).  The DNA between the two operators is looped out.  
“Long-range” cooperative binding between the four sites adds an additional level of interaction and 
increases repression at PR and PL a few fold.  Another consequence of these interactions involves 
the autogenous control by repressor on itself.  The “long-range” interaction between the two 
operators helps to facilitate repressor binding to OR3.  Initial studies with OR3 in isolation rested on 
the assumption that lac-Repressor would bind <10% of the time, and lac-Repressor levels needed 
to increase 10-fold before it would bind OR3 significantly.  However, this long-range interaction 
actually increases the OR3 occupancy rate to 60-70% and reduces resting repressor concentrations 
approximately 3-fold.   
 
Why do the two operators function together?   
If one considers a curve comparing the binding of repressor to the two operator sites as a function 
of repressor concentration, the curve would take a “sigmoid” or highly inflective shape.  In other 
words, at a certain range small changes in repressor concentration would have dramatic effects on 
site occupancy.  Cooperative-binding between the repressor dimers on OR plays a major role in 
defining the curve.  Elimination of cooperativity between repressor monomers has the same effect 
as lowering overall concentration of repressor by 100-fold, even though lowering the concentration 
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of repressor 5-10-fold is enough to vacate the binding sites entirely.  “Long-range” interactions 
only serve to make the curve steeper. In fact, in the absence of an inducing stimulus less than one 
in a million phage infected cells undergoes spontaneous change in growth cycles.  In the presence 
of an inducing stimulus, virtually all infected cells undergo change.  The lambda repressor is a 
remarkably efficient and effective switch. 
 
References:  (Dodd et al., 2001; Dodd et al., 2004; Jacob, 1972; Ptashne, 1986; Revet et al., 1999) 
 
Lessons from Viruses: SV40 
In eukaryotes, like bacteria, promoters direct where RNA polymerase binds and initiates 
transcription.  However in eukaryotes, places where transcription factors bind and function are 
often located much farther away from the promoter that in bacterial genomes.  These places can be 
thousands of base pairs away upstream or downstream from a transcription start site.  The first 
enhancer discovered to affect eukaryotic gene transcription was in a 366 bp fragment from the 
SV40 (simian virus 40) genome.  This enhancer normally serves to direct virus genome 
transcription.  When a plasmid containing the SV40 fragment and any eukaryotic test promoter 
was transfected into cells, transcription was increased compared to the control.  Further tests 
showed that orientation or distance away from the promoter had no effect on SV40’s effectiveness. 
Analysis of the SV40 enhancer showed that it was made up of multiple elements that contribute to 
the overall effectiveness of the enhancer.   
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Lessons from Yeast: Gal4 
Saccharomyces cerevisiae or Baker’s yeast was quickly adopted as a system to study eukaryotic 
gene transcription.  It replicates quickly (about 3-fold slower than bacteria), is easy to grow and to 
handle, and most importantly its genetic sequences can be moved or mutated in a convenient 
fashion.  Eukaryotic gene expression is more complicated than bacterial gene expression because 
in eukaryotic cells, DNA is compacted by histone proteins into structures called nucleosomes.  
Further, eukaryotic RNA must be spliced and transported outside the nucleus for translation to 
occur.  However, we’ll stay focused on the mechanisms of transcription regulators by activators 
and repressors.   
 
Studies have focused on a series of genes important in galactose metabolism.  gal1 is only 
activated when galactose is present in the medium and when glucose is absent.  S. cerevisiae 
metabolizes glucose much more efficiently than it does galactose.  When galactose is present, Gal4 
binds the UAS (upper activating sequence) in the gal1 promoter region and activates transcription 
by recruiting basal transcription machinery and RNA polymerase.  If glucose is present in the 
medium and irrespective of the status of galactose, transcription is actively repressed, because the 
repressor Mig1 binds the gal1 promoter and recruits the Tup1 repressive complex.  As you can see, 
there are a lot of similarities between gal1 and lacZ.  Glucose metabolism dominates galactose or 
lactose metabolism by recruiting Mig1 or lac-Repressor respectively.  The Gal4 and CAP activator 
proteins function by recruiting basal transcription machinery and RNA polymerase directly to the 
promoter.   
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Gal4 is normally associated with Gal80 and kept inactive.  When a cell senses galactose, Gal3 
activates and binds Gal80, changing Gal80’s conformation.  This change in conformation alters 
Gal80’s association with Gal4 such that Gal4 can now bind DNA and recruit basal transcription 
machinery.  In the absence of glucose, inactive Mig1 is phosphorylated and held in the cytoplasm.  
The presence of glucose degrades the kinase responsible for Mig1 phosphorylation.  
Unphosphorylated and active Mig1 enters the nucleus, binds DNA, and recruits the Tup1 
repressive complex.  This example re-emphasizes a popular mechanism among transcription 
regulation: inactive transcription regulators are usually excluded from the nucleus or have their 
activation domains camouflaged. 
 
What separates these studies in yeast from those in bacteria was the recognition that transcription 
factors could be modular in nature.  Gal4 is composed of two different and separable domains, a 
DNA-binding domain and an activation domain.  Gal4 mutants that lack an activation or DNA-
binding domain could not initiate transcription.  When a mutant protein composed of the DNA-
binding domain of the bacterial LexA protein attached to the Gal4-activating domain was 
introduced into cells, gal1 containing a LexA-binding site in place of the Gal4-binding site could 
be activated.  This experiment demonstrated that the activation-domain did not behave in a stereo-
specific manner and could be attached to any DNA-binding domain.  (And formed the basis for the 
popular yeast-two-hybrid technique.)  To further prove this point, the Gal4-activating domain was 
fused directly to the Gal80 protein.  Cells expressing this mutant protein expressed gal1 
irrespective of whether galactose was present in the medium.  
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How does the activation region work?  Why does it behave equally well attached to any DNA-
binding domain?  The activation domain of Gal4 is “acidic” and composed of many negatively 
charged amino acids (like glutamic acid and aspartic acid) and hydrophobic residues.  Mutations in 
the activation-domain that convert negatively charged residues to neutrally charged residues 
weaken the activation potential of the domain.  Conversely, mutations in the activation-domain that 
convert neutrally charged residues to negatively charged residues strengthen the activation 
potential of the domain.  The length of the activation domain is also important, with longer 
activation domains carrying stronger activation potentials.  Finally, mutant proteins consisting of 
activation domains taken from bacterial proteins (e.g. LexA) fused with the Gal4 DNA-binding 
domain can still activate gal1 transcription.  Together, activation domains are transferable, and 
they function by recruiting basal transcription machinery to the promoter.   
 
Activators that work by recruitment must bind DNA to serve their function.  Thus if activators are 
significantly over-expressed in a cell, gene activation is inhibited.  Excess unbound activators soak 
up available transcription machinery, leaving DNA-bound activators unable to perform their 
function.  This phenomenon is called squelching and underscores the fact that transcription 
activators are highly regulated both in cellular location and activity. 
 
References:  (Ptashne and Gann, 2002) 
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Lessons from Higher Eukaryotes 
The study of gene expression in higher eukaryotes is more complicated and more complex than in 
bacteria or viruses.  It was presumed that more complex organisms needed more genes to handle 
the additional information.  Comparative genome studies have refuted this notion.  The 
Caenorhabditis elegans genome contains roughly 20,000 genes, while the Drosophila genome 
contains close to 14,000.  However, Drosophila is clearly a more complex organism than the 
simple nematode worm.  RNA splicing and DNA rearrangement are some potential ways for a 
smaller genome to provide added complexity.  A third possibility is coordinate gene regulation 
programs where multiple factors are required for gene activation.  This third option allows an 
individual protein to participate in different biological processes, because the protein functions 
only when appropriate binding partners are present.  This combinatorial and modular approach of 
gene activation can add levels of complexity.  In support of added regulation at the genetic level, 
there are roughly 300 transcription factors in yeast (counting both sequence-specific transcription 
factors and basal transcription machinery) compared to roughly 3000 transcription factors in 
humans.  Since there are approximately 6000 genes in Saccharomyces, transcription factors make 
up 5% of the genome with a ratio of 1 transcription factor per 20 genes.  The human genome 
contains roughly 30,000 genes, thus transcription factors make up 10% of the genome and there is 
a ratio of 1 transcription factor per 10 genes.  A significant increase in the number of transcription 
factors may be all that is needed to account for the difference in complexity.  
 
To further highlight the differences in complexity, a typical transcriptional unit from a unicellular 
eukaryote contains a simple core promoter, an upstream activator sequence, and a silencer element 
all within a region 100-200 bp away from the TATA box.  In contrast, a typical higher eukaryotic 
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gene contains several enhancers that can be located 5’or 3’ of the gene or even in introns.  Each 
enhancer is likely to contain on average 10 binding sites for roughly three different sequence-
specific transcription factors.  The core promoter is still compact, but at least three different core 
promoter sequences have been identified to recruit TBP and RNA polymerase.  Finally, the 
enhancers important for gene regulation have been found to be as far as 100 kb away from the 
transcription start site (see Igf2, Leighton et al., 1995; Webber et al., 1998).   
 
This complicated organization of regulatory information must be central for allowing detailed 
control of gene expression, and the original hypothesis should now be revised.  Levine and Tijian 
have recently proposed, “that physiological and behavioral complexity correlates with likely 
number of gene expression patterns exhibited during an animal’s life cycle (Levine and Tjian, 
2003).”  Different angles have been used to dissect the mechanisms involved in implementing gene 
expression patterns.  In particular, studies of the nuclear hormone receptor family have addressed 
how individual members within the family activate specific genes and identified the key players 
and mechanisms.  On the other hand, studies of the Drosophila protein Dorsal have elegantly 
shown how a single protein coordinates dorsal-ventral patterning of an embryo by regulating 
numerous gene expression programs.  Finally, studies with the IFNß and IL-2 genes have dissected 
how gene activation occurs on an individual promoter.  These approaches all share the common 
goal of deciphering the “promoter code”, where the regulation of a specific gene can be deduced 
by simple studying the promoter sequence. 
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Nuclear Hormone Receptor Family 
The nuclear hormone receptor (NHR) transcription factor family has been the model for studying 
specificity within a transcription factor family.  Lipophilic hormones regulate gene expression 
through this superfamily, which includes retinoic acid hormone receptor (RAR), thyroid hormone 
receptor (TR), and the peroxisome proliferation-activated receptor (PPAR).  Within the 
superfamily, there exists a class of orphan receptors whose biological ligands have not been 
identified.  Homologs of nuclear hormone receptors have been identified in insects, worms, and 
amphibians.   
 
An important development in the NHR field was the identification and establishment of marked 
DNA binding specificity rules.  Like all transcription factor families, transcription regulation 
depends on interactions between hormone/orphan receptors and the DNA sequence.  Most non-
steroid and orphan receptors (including RAR, TR, PPAR, vitamin D receptor (VDR) and nerve 
growth factor-induced B (NGFI-B)) recognize the consensus half-site sequence 5’-AGGTCA-3’.  
NHR family members form heterodimers with a common member of the NHR family, the retinoid 
X receptor (RXR).  RXR binds DNA on its own duplicated half-site containing the same sequence.  
Importantly, interactions between receptors do not occur until the receptors are bound to DNA.  
Productive interactions between RXR and its partner are determined by the spacing between the 
two half-sites (Mader et al., 1993; Perlmann et al., 1993; Umesono et al., 1991; Zechel et al., 
1994).  The number of base pairs between two sites can range from one to five base pairs, and this 
rule has been generally referred to as the 1-5 rule.  If four base pairs separate the two half-sites, 
TR-RXR heterodimers function; if two base pairs separate the two half-sites, PPAR-RXR 
heterodimers function.  These rules have important implications for transcription specificity.  By 
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simply changing the number of base pairs between two half-sites, signaling pathways that activate 
a particular gene can be interconverted.  To add further complexity, the two half-sites can be 
distinguished between each other by their upstream and downstream locations.  RXR can switch its 
polarity by binding specifically to an upstream or downstream site.  For example, RAR-RXR 
dimers can bind to to half-sites separated by one or five bases, but they are organized in opposite 
polarities and functionally transform from an activator to a repressor respectively (Kurokawa et al., 
1995).   
 
Biochemical and biophysical studies have studied how RXR and its partners recognize spacing.  
Standard biochemical assays did not detect monomeric binding of RXR and individual receptors 
(Mader et al., 1993; Perlmann et al., 1993; Umesono et al., 1991; Zechel et al., 1994) which 
implied that protein-protein interactions must be used to achieve the desired binding affinity.  
Several crystal structures depicting heterodimers bound to DNA have been solved and show an 
asymmetrical placement of subunits in a head-to-tail fashion (Rastinejad et al., 1995; Rastinejad et 
al., 2000; Zhao et al., 2000).  Each receptor interacted with the minor groove of the spacing DNA 
and formed protein-protein interactions with its partner.   When the structure of a RXR-TR 
heterodimer bound to a four bp spacing was compared to a RXR-RAR heterodimer bound to a one 
bp spacing, there were significant differences in protein-protein interactions, the bending of DNA, 
and the conformational flexibility of the receptors.  A detailed study of RXR binding affinity 
demonstrated that RXR in a RXR-RXR homodimer makes contact with 3 bp of the binding site, 
while RXR in a RXR-RAR heteromdimer makes contact with 6 bp of the binding site.  Therefore 
RXR must adopt different conformations depending on its partner, and this flexibility may explain 
why RXR is the common partner.  Taken together, biophysical studies support the hypothesis that 
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DNA-bound NHR family members adopt different conformations to form mutually stabilizing 
interactions with its partner. It is important to remember that a single bp addition or subtraction 
imposes a 3.4 angstrom space change and nearly 36 degrees of rotation between the two half 
complexes.   
 
Because crystal structures are static views of a molecule, pathways of allosteric communication 
within NHR receptors remain to be understood, i.e. how does ligand-binding affect the rest of the 
protein.  With genomic information becoming readily available, comparative sequence analysis 
coupled with structure studies were used to address this question.  Comparative sequence analysis 
functions on the premise that aspects of design important for protein function are preserved 
through evolutionary time.  The sequences for 250 NHR ligand binding domains were compared, 
and 27 residues were identified that link the heterodimerization interface, the ligand binding 
domain, and two regions important for transmission of signal (Shulman et al., 2004).  Mutations of 
predicted residues disrupted the allosteric network and converted functional heterodimers into non-
functional ones. Meanwhile, mutations of residues outside of the network that were spatially close 
did not cause such a dramatic effect.  Another study took a different approach and addressed ligand 
selectivity between two subtypes of estrogen receptors (Nettles et al., 2004).  A series of chimeric 
estrogen receptors were created by protein domain swaps which led to the identification of regions 
in estrogen receptors important for ligand selectivity.  Structurally-guided point mutation receptor 
proteins were used to refine the analysis and identified residues within and outside the ligand 
binding domain to be important for ligand selectivity.  Both papers highlight that ligand 
recognition depends on a network of spatially distributed structural features.   
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Others have studied how DNA sequence spacing may act as an allosteric regulator for NHR 
function.  This has been best studied with the glucocorticoid receptor (GR), where a connection has 
been identified between DNA binding sequence, protein conformation, protein dimerization, and 
transcriptional activity (see review Lefstin and Yamamoto, 1998).  The DNA-binding-domain of 
GR can bind its cognate site in a variety of conformations depending on the sequence of the site, 
serving to present different interfaces for the recruitment of specific co-factors and to help 
determine whether the bound factor will activate or repress transcription.  Recent work has 
identified which GR surfaces are required in a gene-specific manner (Rogatsky et al., 2002; 
Rogatsky et al., 2003).  Similar findings have also been reported for the POU family of proteins 
(see review Phillips and Luisi, 2000).  For example, Pit-1, a pituitary-specific POU domain factor, 
activates growth hormone gene expression in one cell type but restricts expression in another cell 
type (Scully et al., 2000).  This difference is mediated by a two base pair spacing difference in their 
cognate DNA binding sites that presumably affects the conformation of the bound dimer. 
 
The NHR family has been an excellent system to understand transcription regulation.  Where 
marked DNA-binding rules for other prominent higher eukaryotic transcription factor families 
have not been identified and may not exist (for example, C/EBP, E2F, and AP-1), the rules for 
NHR have readily been identified and researchers have used this information to study how 
receptor-receptor interactions work, what interaction surfaces on the receptors are important for 
protein-protein interactions, and how changes in protein conformation may result.  Lessons learned 
for NHR will likely be shared with other transcription factor families. 
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Dorsal 
In Drosophila development, dorsal-ventral patterning is dependent on a sequence-specific 
transcription factor Dorsal, a member of the Rel family of transcription factors (Steward, 1987).  
There are three other Rel family members in Drosophila: Dif, Cactus and Relish.  While Dorsal is 
absolutely required for embryogenesis, Dif, Cactus, and Relish have been shown to be dispensible.  
And while Dorsal is not needed for Drosophila immunity, Dif, Cactus, and Relish have been 
shown to be indispensable.  Therefore, Rel family members in Drosophila may also have specific 
and non-redundant functions.  
 
In early cellularizing Drosophila embryos, Dorsal protein is distributed in a nuclear gradient with 
the highest concentrations in ventral regions and lowest concentrations in the lateral and dorsal 
regions (for a comprehensive review (Stathopoulos and Levine, 2002).  This gradient is responsible 
for the development of mesoderm, neurogenic ectoderm, dorsal epidermis, and amnioserosa.  Past 
studies have demonstrated that Dorsal regulates a network of roughly 25 genes by regulating the 
amount of Dorsal protein available for DNA binding.  Some Dorsal-responsive genes are activated 
by high levels of dorsal protein (twist and snail), others are activated by intermediate levels (sim 
and rhomboid), and finally some respond only to low levels of dorsal protein (sog). 
 
twist is one of the earliest genes activated by the Dorsal gradient and appears in the 12/13 cleavage 
cycle .  It is essential for mesoderm formation and expressed in the 12-14 nuclei located in the 
ventral-most region of the embryo (Thisse et al., 1991).  Analysis of the twist promoter identified 
an enhancer 180 bp upstream from the transcription start site that contained two suboptimal Dorsal 
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binding sites (Jiang et al., 1991; Thisse et al., 1991). A transgenic fly carrying a promoter-reporter 
construct consisting of the twist enhancer driving lacZ expressed lacZ in the predicted regions.  
Mutagenesis experiments changed two base pairs within the Dorsal binding site sequences and 
converted them into optimal Dorsal binding sites (Jiang and Levine, 1993).  A fly carrying this 
transgenic gene expressed lacZ in a much broader range compared with the endogenous gene, with 
18-20 nuclei expressing lacZ.  Thus, the amount of promoter occupancy determined by the Dorsal 
binding site sequence was integral in establishing different limits of gene expression.   
 
snail is another Dorsal target gene that responds to high levels of Dorsal protein.  Snail functions as 
a repressor in the ventral regions of early embryos, although it is expressed in a more limited area 
than Twist.  Snail’s sharp lateral limits of expression are believed to help establish the boundaries 
between mesoderm and neurogenic ectoderm.  Analysis of snail’s promoter region revealed 
binding sites for both Dorsal and Twist (Ip et al., 1992b).  The Dorsal binding sites contain 
suboptimal binding sequences and were located 1-2 kb from the transcription start site, meanwhile 
the Twist binding sites were located 250 bp from the transcription start site.  The sharp pattern of 
Snail expression may be a direct result of the combinatorial nature of the Dorsal and Twist 
gradients.  Experiments mutating the Twist binding sites in the snail promoter resulted in 
inefficient reporter expression; meanwhile experiments mutating the Dorsal binding sites in the 
snail promoter resulted in no reporter expression (Ip et al., 1992b; Szymanski and Levine, 1995).  
When Twist binding sites were engineered into the twist promoter, reporter expression mimicked 
Snail expression patterns (Jiang and Levine, 1993).  In summary, the Dorsal gradient induces 
mesoderm development by inducing two genes (more are possible), twist and snail.  twist is 
directly regulated by Dorsal and expressed in the ventral-most region of the embryo.  The snail 
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promoter contains binding sites for Dorsal and Twist, and its expression is controlled by the 
amount of available Dorsal protein and synergy between Dorsal and Twist.   
 
The slope of the Dorsal protein gradient becomes much steeper in the lateral regions of the embryo 
and allows for as many as five different gradients to be established.  Most Dorsal-responsive genes 
within the lateral regions contain high-affinity Dorsal binding sites.  Gene expression patterns are 
instead largely determined by the location of the Dorsal binding sites and the presence of adjacent 
transcription factor binding sites.  The first major patterning threshold within the neurogenic 
ectoderm specifies a specialized cell layer called the mesectoderm, a layer of cells that eventually 
forms specialized neurons and gial cells associated with the ventral nerve cord.  These cells depend 
on Sim expression.  Snail blocks the expression of Sim in ventral areas (Kasai et al., 1992).  
Similar to the snail promoter, the sim promoter contains binding sites for Dorsal and Twist.  Unlike 
the snail promoter, the Dorsal binding sites in the sim promoter contain optimal binding sequences 
and are located much closer to the Twist binding sites as well as the transcription start site 
(Stathopoulos and Levine, 2002).  These three factors may make sim a more efficient Dorsal-
responsive promoter and explain why Sim expression can occur more laterally than Snail.   A 
recent study has shown that Notch signaling may also impact sim expression (Cowden and Levine, 
2002).  A second patterning region within the neurogenic ectoderm is dependent on Rhomboid 
expression.  Rhomboid expression is controlled by a 300 bp enhancer located 1.7 kb away from the 
transcription start site (Ip et al., 1992a).  Snail blocks the expression of Rhomboid in ventral 
regions.  Analogous to snail and sim, the rhomboid enhancer contains Dorsal and Twist binding 
sites, but the enhancer also contains binding sites for E-box proteins, another family of bHLH 
transcription factors.  Two E-box proteins, Daughterless and Scute, are ubiquitously expressed 
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throughout the developing Drosophila embryo and have been shown to interact directly with 
Dorsal (Gonzalez-Crespo and Levine, 1993; Jiang and Levine, 1993).  Interactions between Twist-
E-box Proteins-Dorsal may further help stabilize Dorsal binding and allow lower levels of Dorsal 
to function on the rhomboid promoter.  When the E-Box binding sites in the rhomboid promoter 
were replaced with Twist binding sites, protein expression was narrowed in comparison to wild 
type (Gray and Levine, 1996).  Taken together, interactions of Dorsal with other transcription 
factors helped establish different thresholds of gene expression within the neurogenic ectoderm. 
 
Finally, the last class of Dorsal responsive genes represented by sog (short gastrulation) was 
identified using a computational method that searched for clusters of Dorsal-binding sites in the 
Drosophila genome (Markstein et al., 2002).  The computational method searched for Dorsal 
binding sites taken from the zen, a Dorsal-responsive protein important for ectoderm development 
(Doyle et al., 1989).  Zen expression is normally activated by several ubiquitously expressed 
transcription factors, but Dorsal represses its expression in the ventral and lateral regions.  zen’s 
promoter contains an enhancer region located 1 kb from the transcription start site that contains 3 
evenly-spaced Dorsal binding sites and 3 binding sites for Cut and Dead Ringer (cut and dri 
respectively).  Studies showed that Dorsal-Cut-Dri complexes recruit a corepressor complex 
Groucho, to the promoter to repress gene transcription (Dubnicoff et al., 1997; Valentine et al., 
1998).  This suggests that interactions between Dorsal-Cut-Dri are integral for zen repression.  
Studies of loss-of-function mutants in Cut or Dri abrogated zen repression.  Mutagenesis 
experiments that removed the binding sites for either transcription factor dramatically broadened 
gene expression patterns, such that protein expression could occur in the ventral-most nuclei.  
Mutagenesis experiments that replaced Dorsal binding sites in the zen promoter with suboptimal 
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Dorsal binding site sequences taken from twist also saw no minimal change in expression patterns 
(Jiang et al., 1992).  This suggested that protein-protein interactions between Dorsal and Cut-Dri 
were strong enough to overcome any Dorsal affinity barriers.  Finally, mutagenesis experiments 
that replaced the suboptimal Dorsal binding sites in the twist promoter with sequences from the zen 
promoter saw a broader range of expression (Jiang and Levine, 1993).  This is another example 
where protein-protein interactions determine expression patterns within the Dorsal gradient.  While 
Dorsal represses zen expression, it activates sog expression (Markstein et al., 2002).  This implies 
that the Dorsal binding site sequences themselves do not determine whether a gene is activated or 
repressed.  Instead, it is the context where the Dorsal binding sites appear in a promoter (i.e. other 
transcription factor binding sites or distance away from the transcription start site).  The 
transcription factor complex that Dorsal interacts with on the sog promoter still remains to be 
identified. 
 
All this work has elegantly uncovered how a single transcription factor can coordinate at least five 
different gene expression programs.  High levels of Dorsal activate twist and snail through 
suboptimal Dorsal binding sites.  Intermediate levels of Dorsal are able to activate sim, because the 
sim promoter contains optimal Dorsal and Twist binding sites located much closer to the 
transcription start site that increases the efficiency of transcription factor binding.  rhomboid is 
similarly structured, except a third transcription factor partner is utilized with Dorsal and Twist to 
establish a slightly different pattern of expression.  Finally, low levels of Dorsal regulate zen and 
sog through multiple high-affinity Dorsal binding sites and an exceptionally strong interaction 
partner.  It is truly remarkable that a single transcription factor can coordinate so much, and Dorsal 
highlights the power of coordinate gene expression programs. 
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In addition to sog, the computation approach identified two other functionally-confirmed, novel 
Dorsal-responsive target genes.  The weakness from this first study was the high rate of false 
positives (77%), but a more recent study that identified neurogenic ectoderm Dorsal-responsive 
genes had a lower rate (29%) (Markstein et al., 2004).  The new study compared more genes 
within a particular expression class to search for more subtle sequence conservations.  In addition 
to using the in silico approach to identifying new Dorsal enhancers.  Drosophila embryos 
constitutively expressing high, intermediate, and low levels of Dorsal protein were compared by 
microarray analysis to identify even more novel Dorsal binding proteins (Stathopoulos et al., 
2002).  A recent study used information from these genomic studies to tackle functional questions 
in Rel-mediated Drosophila immunity.  In depth analysis of the cecropinA1 promoter, a gene 
important in Drosophila immunity demonstrated that Rel and GATA binding sites were required 
for gene activation.  The same Rel-GATA coupling was seen for other members of the cecropin 
family.  Previous microarray studies had identified essential genes involved in response to 
immunogenic challenge, therefore the authors addressed whether a Rel-GATA linkage was 
indicative for immunity related genes (De Gregorio et al., 2001).  When the top 50 most induced 
genes from that study were probed for consensus binding sites for Rel and GATA family members, 
nearly half of the genes showed close linkage between the two sites (Senger et al., 2004).  
Moreover, a Rel-GATA linkage was also required for expression in larval fat bodies.  Promoters 
that contained isolated Rel or GATA binding sites did not express in larval fat bodies.  To 
demonstrate the synergy between Rel and GATA, a transgenic fly was created that carried a 
GATA binding site engineered into a normally Rel-responsive, GATA-independent gene.  The 
transgenic gene expressed in larval fat bodies.  As seen with twist, a few base pair changes within 
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the DNA sequence altered gene expression patterns.  Unlike embryogenesis where Dorsal is the 
single Rel family member responsible, it still remains to be seen which Rel or GATA family 
members are required for the Rel-GATA synergy.  While a GATA-Rel synergy sounds too simple 
to explain immunity and larval fat body expression, there are still subtle differences that provide 
addition regulation.  Orientation, spacing between the two sites, and placement relative to the 
transcription start site were all factors that disrupted specificity and imposed certain restraints.  
 
Specific Genes 
The virus inducible interferon-ß promoter has become the standard example of how combinatorial 
interactions between transcription factors can give rise to a highly specific gene expression 
program.  The IFNß gene is normally silent but is highly induced during viral infection.  This 
behavior is due to an enhancer located in the -110 to -45 region relative to the transcription start 
site.  Three positive regulatory domains have been identified and are recognized by different 
transcription factor families: NF-κB, IRF, and ATF-2/c-Jun heterodimer.  IFNß transcription is 
induced when each transcription factor is recruited to the promoter in a step-wise fashion.  None of 
the regulatory domains can function alone.  Thus, the interferon-ß enhancer acts as an endpoint for 
many regulatory inputs, which filters and processes information in a way that permits response 
only to viral infection.  Duplicated copies of a particular transcription factor binding site may act as 
a virus inducible enhancer, but these synthetic enhancers are often less inducible and respond to 
inducers other than virus infection.  In other words, the enhancer is not only a collection of 
transcription factors binding to their respective sites; the final response comes from synergistic 
interactions between each of them to form an “enhanceosome.” Similar to the SV-40 enhancer, the 
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IFNß enhancer does not need to be in close proximity to the core promoter.  When placed 
thousands of bases away, the enhancer still functions.  
 
The discovery of HMG I(Y) was an important step to elucidating the mechanisms that controlled 
the IFNß enhancer.  HMG I(Y) is not a typical transcription factor in that it does not directly recruit 
other proteins.  Instead, it unbends and relaxes DNA, lowering the free energy required for 
activator binding and orchestrating a series of activator-activator interactions.  As a result, 
relatively weak interactions between proteins are strengthened, and the final result is a remarkably 
stable nucleoprotein complex. 
 
The regulation of the IL-2 gene has also been studied extensively.  IL-2 plays a key role in the 
mammlian immune system by driving the proliferation of B, T, and NK cells.  Its expression is T-
cell specific and very tightly regulated, such that no basal activity can be detected in resting T cells 
and a strong induction occurs after T cell activation.  How is IL-2 so tightly regulated?  IL-2’s 
proximal promoter has been well defined with numerous transcription activation elements 
including NF-κB, NF-AT, Oct-1, and AP-1 (see review Rothenberg and Ward, 1996).  More recent 
studies have shown that chromatin may play a significant role in IL-2 gene activation.  In resting T 
cells, a nucleosome is positioned over the proximal promoter that prevents the binding of most 
transcription factors to the promoter (Attema et al., 2002).  When T cells are activated, the 
nucleosome gets remodeled allowing transcription factors to bind their respective sites and activate 
gene expression.  This remodeling is dependent on cRel specifically (Rao et al., 2003).  How cRel 
provides this nonredundant function remains to be understood.  However, this is another example 
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where cRel is specifically required for gene activation; IL-12 production in macrophages was also 
shown to be cRel dependent as well, although the mechanism is also unclear (Sanjabi et al., 2000).   
 
Chromatin 
Chromatin remodeling complexes have been shown to be important in integrating complex 
promoter regulatory sequences.  Further, the expansion of chromatin remodeling complexes and 
basal transcription machinery over evolutionary time has mimicked the expansion of sequence-
specific transcription factors. 
 
While transcription specificity within the NF-κB family has not been significantly addressed in a 
thorough manner, studies have shown that chromatin remodeling plays an important role in NF-κB 
dependent gene regulation (Saccani et al., 2001).  NF-κB responsive genes have different temporal 
patterns of gene activation in response to TNF stimulation.  By monitoring histone acetylation and 
p65 binding statuses, NF-κB responsive genes that induced early had constitutive H3 acetylation 
correlated with p65 binding at early time points.  On the other hand, NF-κB responsive genes that 
induced late had inducible H3 acetylation and p65 did not bind until H3 acetylation had occurred.  
While this study and cRel’s role in IL-2 remodeling only showed correlations between NF-κB and 
chromatin remodeling, it will be very interesting to understand how and if NF-κB interacts directly 
with chromatin remodeling complexes. 
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Abstract 
The NF-κB transcription factors consist of dimeric proteins of the Rel homology family. They 
activate many promoters containing highly divergent κB-site sequences.  We have generated cell 
lines lacking individual and multiple NF-κB proteins and used them to establish interactions 
between components of the NF-κB-IκB signaling system.  Functional compensation within the 
family of dimers was evident in knockout cell lines. Analysis of transiently transfected genes gave 
an impression of promiscuity that was not borne out by analysis of endogenous genes. Using 
TNFα as an inducer, a panel of endogenous genes showed a wide a range of subunit specificities as 
well as highly variable kinetics of induction.  Comparing the function and subunit specificity of 
genes with the sequence of the κB DNA-binding site we found little correlation, indicating that 
NF-κB family member specificity for endogenous promoters is not solely encoded by the κB site 
sequence itself. 
 
 
 
 48
  
INTRODUCTION  
Cell signaling molecules such as transcription factors are encoded in gene families whose members 
have distinct yet overlapping functions.  The fact that increasingly complex genomes contain a 
greater number of gene family members rather than novel families (Lander et al., 2001) suggests 
that diversity within a gene family may provide for specificity and versatility in the regulation of 
cellular responses.  Characterizing the specific functions of the members of transcription factor 
gene families contributes to our understanding of gene regulatory networks and to the development 
of specific therapeutic strategies.  For example, biochemical studies of the nuclear hormone 
receptor family have shown that the spacing between two tandem cognate DNA half-sites 
determines which family members bind and function (Rastinejad, 2001).  Similarly within the large 
zinc finger transcription factor family, biochemical and biophysical characterization of DNA-
protein interactions is the basis for synthetic transcription factor engineering (Wolfe et al., 2000).   
However, for many other transcription factor families, such as the C/EBP (Ramji and Foka, 2002), 
E2F (Trimarchi and Lees, 2002), AP-1 (Chinenov and Kerppola, 2001; Mechta-Grigoriou et al., 
2001), and NF-κB families, marked DNA-binding specificity rules have not been identified.  
Indeed, the raison d’être of multiple members within signal transduction protein families may not 
be molecular interaction specificities but could be found in their own differential regulation.  
Considering the immediate regulators of NF-κB activity, the IκB protein family, for example, the 
difference between family members that is of primary physiological importance appears to be 
regulation of synthesis, as demonstrated by the fact that IκBα knockout lethality was rescued by 
placing IκBß under the control of the IκBα promoter (Cheng et al., 1998).  A quantitative analysis 
of the signaling characteristics of IκB family members has supported that conclusion (Hoffmann et 
al., 2002).  
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The NF-κB (also called NF-κB/Rel) family of dimeric transcription factors mediates cellular 
responses to a wide variety of different stimuli by regulating the expression of a large number of 
genes of highly diverse functions (Pahl, 1999).  Mouse knockout studies have revealed this 
pleiotropic signal transducer to be involved in inflammatory and stress responses, the control of 
cell cycle, apoptosis, growth and proliferation, cell-cell communication, lymphocyte development 
and maturation, and neuronal learning (Gerondakis et al., 1999; Meffert et al., 2003).  The 
functional transcription factors consist of pairs taken from the NF-κB protein family (p50, p52, 
p65, cRel, RelB), proteins that utilize the Rel homology domain (RHD) for DNA-binding and 
dimerization.  Their cognate DNA-binding element, the κB-site, is found in the promoters of NF-
κB responsive genes but displays a remarkably loose consensus, often described as G-5G-4G-3R-2N-
1N0Y+1Y+1C+2C+3 (Ghosh et al., 1998).  The heterogeneity of κB-sites has been thought to confer 
specificity of regulation mediated by differential affinities of NF-κB isoforms.  Purified 
recombinant RHD protein dimers could indeed be shown to select differential optimal DNA-
binding motifs from a pool of random oligonucleotides (Kunsch et al., 1992).  Similarly, one study 
with transfected promoter-reporter constructs showed that multimerized κB-sites from one of three 
different promoters (Igκ, MHC H2, and IFN-ß) exhibited differential responses when co-
transfected with p50 and/or p65 expression plasmids (Fujita et al., 1992).   
 
However, more recent structural studies did not reveal evidence for highly sequence-specific 
DNA-NF-κB interactions, with base-specific contacts within the p50 homodimer structure 
involving primarily 5’-G-5G-4G-3 (Ghosh et al., 1995; Muller et al., 1995) and contacts within the 
p65 homodimer structure involving primarily 5’-G-4G-3 (Chen et al., 1998b).  In fact, these studies 
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have not revealed sufficient DNA base contacts to rationalize κB-site sequence-specific binding.  
Though homodimers of p65 or cRel require only a 9bp sequence for binding, this may be 
contained within certain 10bp consensus-conforming κB sites.  X-ray structures of the p50:p65 
heterodimer bound to different κB-sites, such as those derived from the immunoglobulin and HIV 
enhancers G-5G-4G-3A-2C-1T0T+1T+2C+3C+4 (Chen et al., 1998b), the interferon-ß enhancer G-5G-4G-
3A-2A-1A0T+1T+2C+3C+4 (Berkowitz et al., 2002; Escalante et al., 2002), and the urokinase 
plasminogen activator gene (uPA) promoter G-5G-4G-3A-2A-1A0G+1T+2A+3C+4 (Chen-Park et al., 
2002) demonstrate that NF-κB binds a variety of sequences.   Furthermore, the two RHD domains 
contained in each dimer constituent relate to each other differently in different structures and lead 
to different degrees of DNA bending (Chen and Ghosh, 1999), emphasizing the remarkable 
permissiveness of NF-κB-DNA interactions. 
 
Despite the difficulty in discerning specificity at the level of DNA-protein interactions, mice 
deficient in a single RHD protein show specific phenotypes.  rela-/- animals are embryonic lethal 
with massive hepatocyte apoptosis (Beg et al., 1995), while crel-/- mice develop normally but have 
defects in lymphocyte proliferation (Kontgen et al., 1995).  In part, family member-specific 
functions can be inferred by tissue specific expression.  While p65 appears to be ubiquitous, cRel is 
expressed constitutively primarily in mature monocytic and lymphocytic lineages (Liou et al., 
1994), while in others, such as fibroblasts, only following stimulation  (Grumont and Gerondakis, 
1990).  In addition, there are differences in the molecular characteristics of RHD family members: 
transfection studies have identified activation domains in p65 and cRel, but not in p50 and p52 
(Ghosh et al., 1998).  DNA-binding assays were used to identify dimerization rules: p50 (and 
presumably p52) can partner with all RHD family members including themselves, while RelB and 
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cRel do not appear to engage in homotypic interactions.  RelB, furthermore, does not appear to 
dimerize with p65 or cRel.  Little is known about how the results from in vitro biochemical 
characterizations of RHD proteins can serve to explain physiologically relevant functional 
specificity in gene regulation, because selectivity of endogenous κB-site containing promoters 
remains largely unexplored.  In fact, in the case of the IL-12 promoter, results from cell-free or 
extra-chromosomal templates are shown not to recapitulate endogenous promoter specificity 
(Sanjabi et al., 2000). 
 
Genetic approaches are suitable to address questions of in vivo mechanistic specificity, but must 
take into account the possibility of interdependent regulation of factors in mammalian signaling 
networks; resulting compensatory mechanisms among functionally related molecules may lend 
increased robustness to signaling systems and affect the phenotype of genetic deletions.  Here, we 
have undertaken a genetic analysis of RHD proteins with respect to NF-κB-dependent gene 
activation by creating a panel of single and double knockout cell lines.  We have biochemically 
characterized NF-κB activation within them, and measured the TNFα responsiveness of a diverse 
set of NF-κB target genes.  Our results reveal that RHD protein family members exhibit 
differential target gene specificities and demonstrate that a combination of genetic and biochemical 
analyses can be applied to decode functional specificity rules of gene promoters in mammalian 
cells.  
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RESULTS 
 
Cross-regulation and compensation within the NF-κB-IκB regulatory system 
The dominant κB-binding activity induced by TNFα in fibroblasts is composed of p50 and p65, 
the mature gene products of the nfκb1 and rela genes.  Microarray studies with nfκb1-/-rela-/- 
doubly deficient cells have confirmed their key role in activating most TNFα-responsive genes; 
fibroblasts lacking both factors show no activation of genes controlled by NF-κB (A.H. and D.B., 
in preparation). To address the specific roles of p50 and p65 in NF-κB-dependent gene expression, 
we generated fibroblast cell lines from nfκb1-/- (Sha et al., 1995), rela-/- (Beg et al., 1995) and 
nfκb1-/-rela-/- embryos (Horwitz et al., 1997).   Western blots confirmed that p50 and p65 proteins 
were absent in respective knockout cell lines (Fig. #1A), while other RHD proteins remained, 
though at somewhat altered levels.  In particular, p52 levels were enhanced in nfκb1-/- cells, cRel 
levels were increased in rela-/- cells, and cRel as well as RelB levels were somewhat reduced in 
doubly deficient cells. Strikingly, rela-/- cells contained markedly reduced levels of IκBα and IκBß 
proteins, while all three IκB proteins were reduced to almost undetectable levels in doubly 
deficient cells (Fig. # 1B).   
 
To investigate the result of genetic knockouts within the RHD family on the activated NF-κB 
transcription factor, we examined the induction of nuclear κB-binding activity in response to 
TNFα stimulation in wild type and mutant cells lines (Fig. #2).  Gelshift and Western blot analyses 
of the nuclear and cytoplasmic compartments of wild type cells revealed a characteristic biphasic 
induction of nuclear NF-κB (Fig. #2A) that results from the coordinated degradation and synthesis 
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of IκB family members (Fig. #2B).  Cells lacking p50 showed only a marginal reduction in κB-
binding activity (Fig. #2C) with no alteration in the temporal regulation.  In p65-deficient cells, 
however, induction produced two distinct κB-binding activities that did not undergo post-induction 
repression (Fig. #2E), correlating with defective IκBα protein synthesis (Fig. #2F).  Finally, no 
significant κB-binding activity was induced at any time point within a 6 hour TNFα time course in 
doubly deficient cells (Fig. #2G).  These results confirm that p50 and p65 make up the major 
constituents of NF-κB in fibroblasts.  However, neither p50 nor p65 single knockout cells were 
deficient in κB-binding activity.  In addition, the temporal regulation of nuclear NF-κB is altered in 
rela-/- cells. 
 
Compensation and specificity on non-chromosomal promoter DNA 
To characterize the molecular composition of induced κB binding complexes, we employed 
antibodies specific for each Rel protein in gel mobility supershift analyses of nuclear extracts made 
after 30 minutes of TNFα stimulation. As expected, nuclear κB-binding activity in wild type cells 
(Fig. #3A) was sensitive to antibodies specific to p50 and p65; indeed distinct complexes 
comprising dimers of p65 (upper arrow), p50:p65 (lower arrow) and p50 (data not shown) were 
identified.  The lower complex (indicated by an asterisk) appeared to be non-specific as revealed 
by competition analysis with wild type and mutant double-stranded oligonucleotides (lanes 2 and 3 
in each panel).  Not surprisingly, complexes apparent at long exposure in extracts from  
nfκb1-/-rela-/- double knockout cells (Fig. #3D) were not recognized by any of the NF-κB family 
antibodies and were not specifically competed by double-stranded oligonucleotides. 
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Turning to single knockouts, anti-p50 antibodies, as expected, did not recognize κB-binding 
complexes in extracts derived from nfκb1-/- cells (Fig. #3B), nor did anti-p65 antibodies recognize 
κB-binding complexes derived from rela-/- cells (Fig. #3C).  Instead, antibodies directed against 
p52 ablated the nfκb1-/- complex of the same mobility as the p50:p65 complex found in wild type 
cells.  Similarly, antibodies directed against cRel supershifted the analogous rela-/- κB-binding 
complex, as well as a much weaker, slower migrating complex that may correspond to a cRel 
homodimer. These results strikingly revealed molecular compensation within the NF-κB/Rel 
family; however, not every family member functioned interchangeably with one another.  
Molecular compensation rules appear to reflect previously noted homology relationships, and the 
results from molecular characterization studies that inferred structural and functional similarities 
between p50 and p52, and p65 and cRel proteins (Ghosh et al., 1998).   
 
These results suggest multiple mechanisms of cross-regulation between the RHD and IκB protein 
family members.  One known mechanism is transcriptional feedback: cRel (Grumont et al., 1993), 
RelB (Bren et al., 2001) and IκBα (Scott et al., 1993) are known NF-κB target genes, which 
presumably explains observed decreases in protein levels in p50 and p65 doubly deficient cells, as 
well as the absence of postinduction repression of nuclear NF-κB in rela-/- cells.  Another cross-
regulation mechanism may be based on the protein stability differential between uncomplexed and 
complexed polypeptides; indeed reduced IκB protein levels in mutant cells may be the result of the 
loss of NF-κB dimers available for complex formation.  Similar reasoning might explain the 
increased levels of p52 and cRel-containing complexes in nfκb1-/- and rela-/- cells by respective 
substitution in dimer formation.   
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To address the transcriptional activity of p50- or p65-deficient NF-κB complexes, we utilized 
transient transfections with promoter-reporter constructs driven by multimerized κB-sites.  Each 
construct contained κB-binding site sequences taken from one of three different promoters: Igκ, 
MHC H2, or interferon-ß.  These constructs had previously been shown to have differential 
responses to co-transfected p50 and p65 expression plasmids (Fujita et al., 1992).  We observed 
significant transcriptional activation of κB-site-containing reporters in wild type fibroblasts 
following TNFα stimulation (Fig. #4A, red bars).  Such activation was dependent on the presence 
of κB-sites (lower right panel) and was minimal in cells deficient in both p50 and p65 (black bars).   
However, fibroblasts lacking only one family member, either p50 (green bars) or p65 (blue bars), 
still showed significant levels of activation, with some reduction observed (about half) in rela-/- 
cells.  Surprisingly, the results were similar for all three promoter-constructs.  Those κB-sites also 
revealed little difference in NF-κB complexes when employed in a gelshift assay with nuclear 
extracts from above-described TNFα-stimulated mutant cells lines.  Each probe revealed p50:p65 
complexes in wild type cells, p52:p65 complexes in nfκB1-/- cells, and p50:cRel complexes in  
rela-/- cells (Fig. #4B, data not shown).  However, we note that the H2 κB-probe does not show 
p65 homodimer complexes in nfkb1-/- cells and appears to impart somewhat lower transcriptional 
activity than the other κB-sites. 
 
The above-described analyses indicate that molecular compensation occurs within the RHD 
protein family and results in functional compensation on extra-chromosomal templates; the 10bp 
κB-sites did not reveal much specificity for NF-κB isoforms, though certain sequences may 
certainly provide a restriction with respect to the entire panel of possible dimers.  We next turned 
to the regulation of endogenous genes to determine whether they exhibit similar promiscuity.  
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However, compensation evident in single knockouts required the inclusion of fibroblast cell lines 
that are nfκb1-/-nfκb2-/- and rela-/-crel-/- doubly deficient, as well as single knockout controls 
derived from nfκb2-/- and crel-/- embryos.  For example, to address the function of p65 in wild-type 
cells, rela-/-crel-/- cells are an informative genotype because the results will not be affected by cRel 
compensation for the loss of p65.  In turn, we can address the question of molecular specificity of 
RHD proteins in transcriptional activation by determining whether molecular compensation by 
cRel results in functional compensation on endogenous promoters. 
 
Systematic genetic analysis of a transcription factor family 
To undertake such a study, we interbred NF-κB knockout mouse strains and derived 3T3 fibroblast 
lines that were doubly deficient in p50 and p52 or p65 and cRel.  We also derived control lines 
from nfκb2-/-(Caamano et al., 1998) and crel-/- (Kontgen et al., 1995) embryos.  Gel mobility shift 
assays were then used to detect κB-binding complexes in extracts made from each of these cell 
lines following TNFα stimulation (data not shown); their molecular composition was determined 
by employing the previously used panel of antibodies.  As summarized in Table 1, each mutant cell 
line showed a characteristic set of TNFα-inducible RHD proteins that gave rise to particular κB-
binding activities.  Therefore, the systematic panel of mutants allowed us to distinguish between 
NF-κB-dependent promoters that strictly required a particular RHD protein for activation and those 
promoters that had a broader requirement for one or the other RHD protein subclass.  Specifically, 
we could distinguish genes that require p50 for TNFα-induced activation, those on which either 
p50 or p52 must function, and those that do not require either protein for NF-κB-dependent 
activation.  Similarly, those same genes could be further classified according to their requirement 
for p65 or cRel. 
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For a quantitative, yet high throughput analysis of endogenous gene expression, we used a 
multiplex RNAse protection assay that allows independent monitoring of up to 10 different 
messenger RNA transcripts (Fig. # 5A). Two house keeping genes, GAPDH and L32, allowed for 
normalization such that consistent expression units can be used to compare different experiments.  
Multiple data sets from four different wild-type cell lines demonstrated reproducibility, which 
therefore allows comparison of datasets from different cell lines bearing different mutations.  
Interestingly, a detailed time course revealed that different genes have widely different kinetics of 
activation.  For example, our panel of genes included several chemokine genes (Fig. # 5B).  After 
TNFα stimulation, MIP-2 mRNA levels increase as early as 15 minutes, reaching a peak at 1 hour, 
and disappearing by 2 hours.  On the hand, RANTES transcripts are not detectable until 2 hours 
post-stimulation and continue to rise beyond 8 hours.  Finally, MCP-1 and IP-10 display an 
intermediary profile.  The dynamic nature of NF-κB activation emphasizes the importance of 
conducting gene expression assays in detailed time courses. 
 
Differential NF-κB/Rel protein requirements 
We focused our attention on 9 genes that represent diverse classes of NF-κB responsive genes, are 
induced in fibroblasts by TNFα stimulation, and the mRNA levels of which could be monitored 
reliably by RPA.  These genes were: IκBα, aforementioned chemokine genes RANTES, IP10, 
MCP-1, and MIP-2; the immune regulatory factor LIF; the growth factor M-CSF; transcription 
factor junB; and apoptosis-inducing TNF receptor family member Fas.  Quantitative RPA results 
for each gene are summarized in three graphs which group related genotypes (Fig. #6).  Graphs in 
the left column demonstrate NF-κB dependence because cells lacking both p50 and p65 have no 
 58
  
NF-κB-mediated activity; those in the center column address dependence on p50 and/or p52 
proteins, and those in the right column address dependence on p65 and/or cRel proteins.  An eight 
point time course extending to 8 hours following the onset of TNFα stimulation revealed diverse 
kinetics in gene activation.  In each case, transcriptional induction proved to be protein synthesis 
independent but cycloheximide did affect the transcript levels of some genes at time  points 
following initial activation (A.H., unpublished results). TNFα activation of all genes proved to be 
NF-κB-dependent as determined with cells lacking both p50 and p65 (left column). Two genes, M-
CSF and junB, showed residual induction in the absence of NF-κB, but the NF-κB contribution to 
their activation was found to be reproducible and analyzable with respect to NF-κB protein 
requirement (see below).  Interestingly, junB transcription was found to be highly induced in NF-
κB knockouts at the time when these cells undergo widespread TNFα-induced apoptosis, 
indicating that this gene is subject to additional transcriptional regulation mechanisms independent 
of NF-κB.   
 
Turning to p50 and p52 NF-κB family members, we expected no activation defects in nfκb2-/- 
fibroblasts, because our supershift analysis did not reveal any p52 protein in κB-binding complexes 
in TNFα stimulated wild type cells.  As shown in the center column graphs, that is in fact the case; 
however, some genes, notably IP-10, appear to be super-induced at later time points in nfκb2-/- 
cells.  Surprisingly, TNFα-induced gene expression is largely unaffected by p50 deficiency (green 
line) as well. In fact, only one gene in our collection, LIF, cannot be activated by TNFα 
stimulation in nfκb1-/- cells.  The major reason for such a mild gene expression phenotype appears 
to be efficient functional compensation by p52, because the activation of several genes, such as 
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RANTES, IP-10 and M-CSF, is defective in cells lacking both p50 and p52.  Thus, NF-κB-
dependent genes appear to fall into three categories: those requiring p50 for induction in TNFα-
stimulated fibroblasts, those on whose promoters either p50 or p52 can efficiently function, and 
those whose TNFα induction can proceed without either of these two RHD proteins. 
 
Transcript quantitation for these genes in TNFα-induced cells deficient in cRel, p65, or both is 
shown in the right column of Fig. #6.  Because cRel was not found in κB-binding complexes in 
wild type fibroblasts, it is not surprising that none of the nine genes are significantly attenuated in 
crel-/- cells (red lines).  In fact, most genes appear to be dramatically dependent on the p65 protein 
(green lines), although in some cases (e.g. IκBα, LIF, M-CSF) we saw significant transcript levels 
at the latest time points that are probably the cumulative result of residual transcriptional initiation 
activity.  However, the chemokine MCP-1 and the transcription factor junB did not exhibit such a 
strict requirement for p65 because cRel could also function on these promoters (compare green and 
black lines).  Importantly, we find that no NF-κB-dependent promoter can be activated in the 
absence of both p65 and cRel.  This observation confirms that these two proteins contain the 
principal activation functions within κB-binding complexes, while p50 and p52 can be considered 
binding partners that have essential functions in a subset of gene induction events. 
 
Our panel of knockout cell lines revealed that endogenous genes have remarkably different 
requirements for RHD proteins when induced by TNFα in fibroblasts.  While none could be 
induced in cells lacking both p50 and p65, or p65 and cRel, the ability to be induced in nfκB1-/-, 
nfκb1-/-nfκb2-/-, or rela-/- cells was gene-specific (Table 2, left columns).  Therefore, specific RHD 
protein requirements are determinable for every TNFα induced gene in fibroblasts, as summarized 
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for the group of nine NF-κB-dependent genes that were part of this study (Table 2, right columns).  
Within this small sample of genes, the pattern of RHD protein requirement does not appear to 
correlate with the temporal control of gene expression (indicated in the second column) or the 
known or presumed function of the gene product; the 6 secreted immune response regulatory 
proteins represented here (RANTES, MCP-1, IP-10, MIP-2, M-CSF, and LIF) cover diverse 
temporal kinetics as well as diverse combinations of RHD protein requirements.   
 
 
DISCUSSION 
 
We have presented genetic evidence that mammalian gene activation requires not only specific 
transcription factors, but specific members of the RHD transcription factor family for the activation 
of endogenous NF-κB-responsive genes. However, in vitro binding assays with extracts from cells 
harboring deletions of specific family members reveal DNA-binding characteristics that are 
sufficiently overlapping that functional specificity of family members cannot be reproduced on 
naked templates in transient transfections.  In fact, in the absence of exogenously expressed family 
members, transiently transfected promoters appear to be remarkably promiscuous with regard to 
family member-specific requirement, though some κB-site sequences may be more specialized, 
restricting access to a subset of NF-κB dimers. 
 
Specificity was revealed when taking a genetic approach to a mechanistic question.  The specific 
RHD protein requirement for the activation of an endogenous promoter implies that a particular 
subset of all available RHD protein dimers (Table 1) is capable of functioning on the promoter in 
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question.  Thus the RHD protein requirement (Table 2) can be translated into the subset of RHD 
protein dimers that appear capable of mediating the induction of each gene in our study (Table 3).  
For example, LIF induction by TNFα is abolished in both nfκb1-/- as well as rela-/- single knockout 
cells leading to the conclusion that of all possible RHD protein dimers only the p50:p65 
heterodimer is functional on this promoter.  In contrast, IP-10 (as well as M-CSF, and RANTES) 
can be induced by dimers containing either p50 or p52, with p65 being a required partner.  A 
representative of a third group is MIP-2; this chemokine (as well as IκBα and Fas) is induced by 
p65-containing complexes that may not only be heterodimers with p50 or p52, but can also be 
p65:p65 homodimers.  MCP-1 and junB exhibited the least stringent RHD protein requirement 
with NF-κB/Rel complexes consisting of either p65 or cRel capable of functioning on these 
promoters.  While cRel protein can partner with p50, p65 can function as a homodimer or as a 
heterodimer with p50 or p52 to activate transcription of these two genes. 
 
Determinants of NF-κB protein requirements 
Because individual NF-κB dimers have been shown to have particular binding sequence 
preferences in vitro (Kunsch et al., 1992), we examined whether RHD protein requirements can be 
correlated with the sequence of the κB-site.  Such a correlation would indicate that DNA-protein 
interaction affinity, or more precisely Kon and/or koff rates, of RHD protein dimers to specific κB 
site sequences determine which RHD protein dimers are functional on a particular promoter.  The 
promoters for most of the genes in this study have been previously investigated by standard 
transiently transfected reporter assays that led to the identification of the apparent functional 
transcription factor binding sites.  For LIF, we used human and mouse genomic databases and 
previous promoter studies to identify a novel κB-binding element.  Grouping the NF-κB-dependent 
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genes in our study according their specific RHD protein requirement in Table 3 failed to reveal a 
correlation with κB-site sequences.  In fact, genes whose TNFα induction can be mediated by the 
same set of RHD protein dimers, such as RANTES, IP-10, M-CSF, contain different κB-site 
sequences that are responsible for this induction.  Conversely, promoters containing the same κB-
site sequence (GGGAATTTCC), such as MIP-2 and MCP-1, exhibit different RHD protein 
requirements.  Furthermore, focusing on genes that can be activated by p65 homodimers (MCP-1, 
junB, MIP-2, IκBα and Fas) we cannot discern any common features in the relevant κB-site 
sequences.  In each case, the κB element is embedded in a promoter that is bound by many 
proteins, such as neighboring transcription factors, co-activators, and chromatin components that 
may interact with NF-κB/Rel dimers bound at the κB-site.  The results of our genetic analysis 
suggest that the ability of RHD protein dimers to function on a particular promoter is not solely 
determined by DNA-protein interactions at the κB-site.  While the regulatory control regions of the 
genes in this study have previously been characterized, we cannot rule out that NF-κB may 
function via unrecognized binding sites, whose sequence may not be conserved between mouse 
and human.  Mutations of endogenous sequences via knock-in technology or methodologies that 
allow faithful expression of transgenic constructs will be needed to confirm and extend our 
conclusions. 
 
Interactions with DNA is likely to restrict the subset of possible transcription factors that may 
function at a particular promoter element, and within the family of κB sites it is known that p65 or 
cRel homodimers bind better to 9bp than 10bp sites.  However, our results (based on the highly 
divergent set of 10bp κB sites) point to the importance of protein-protein interactions within 
promoter-DNA assemblies in determining a specific family member requirement and generating 
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transcriptional specificity in vivo.  Transcriptional synergy (Lin et al., 1990) between adjacent 
transcription factors and within enhanceosomes (Thanos and Maniatis, 1995b), as well as specific 
co-activator requirements (Merika et al., 1998), have been observed in non-chromosomal 
experimental systems  and have long been thought to play a role in generating specificity through 
combinatorial control.  Differential specificity of NF-κB protein family members in interactions 
with contextual transcriptional factors may thus account for family member specific requirement 
for gene activation.  Chromatin has also been shown to control NF-κB/Rel accessibility in vivo 
(Saccani et al., 2001) and may in fact do so in a manner that is specific for a subset of RHD protein 
dimers.  Furthermore, some genes require chromatin reorganization for gene activation 
(Lomvardas and Thanos, 2002), and this may be dependent on protein-protein interactions specific 
to a particular family member. 
 
Other groups have taken complementary approaches to studying transcription factor specificity.  In 
particular, Farnham and colleagues used chromatin immunoprecipitation in combination with 
microarray technology (ChIP-Chip) to examine the role of a single member of the E2F family 
across a wide spectrum of genes (Weinmann et al., 2002), while Young and colleagues have begun 
to characterize extensive networks of transcriptional control in budding yeast (Lee et al., 2002).  
Recently, ChIP experiments have revealed differential NF-κB dimer recruitment to target 
promoters that may complement the present study (Saccani et al., 2003).  While NF-κB occupancy 
as assayed by ChIP does not indicate the functional activity of the bound dimer without the use of 
genetic tools, such assays indicate that transcriptional control may involve the dynamic interplay of 
different dimers to attenuate or sustain transcriptional activity (also A.H. and D.B., manuscript in 
preparation).  Perfecting the ChIP-chip technology to allow for a comprehensive characterization 
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of occupancy states of regulatory regions will shed light on promoter architecture. Complementing 
that approach with transcript measurements in a variety of relevant knockouts may illuminate the 
operative promoter code, and in particular the question of family member specificity.  
 
Are distinct κB-site sequences functionally equivalent?  While our genetic analysis has failed to 
correlate functional requirement with κB site sequence, and NF-κB co-crystal structure studies do 
not reveal extensive NF-κB dimer-specific DNA-binding contacts (Chen and Ghosh, 1999), this 
does not rule out that the κB-site sequence plays a functional role.  In fact, structural comparisons 
of the p50:p65 dimer bound to different κB-site sequences have revealed significant differences in 
conformation (Chen and Ghosh, 1999).  The particular conformations of DNA bound NF-κB 
complexes (probed by protease sensitivity and X-ray crystallography) have indeed between 
correlated with their ability to transactivate on transfected promoters (Chen-Park et al., 2002; Fujita 
et al., 1992); however it is unknown whether the conformational state of NF-κB complexes may 
have similar importance on chromosomal promoters, and whether a particular conformation of an 
NF-κB dimer may be functional on one promoter but not another.  In addition to examining 
binding affinities, investigating the conformations of NF-κB dimers bound to κB elements and the 
functional consequence within the context of endogenous regulatory region is likely to bring 
further understanding to the promoter code. 
 
Multiple protein-DNA complexes may be able to assemble on a given promoter depending on the 
cell-type and stimulus (Falvo et al., 2000).  Because the κB-site sequence is not the sole 
determinant of the specific RHD dimer requirement, we may find that the specific RHD protein 
requirement for the activation of a particular gene is also specific to cell type and stimulus.  If 
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combinatorial control by multiple promoter-bound transcription factors generates specific 
transcription factor requirements, it can form the basis for the inclusion or exclusion of a particular 
gene in specific gene expression programs in response to multiple activation pathways.   
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MATERIALS AND METHODS 
Cell culture and transfections 
Immortalized fibroblast cell lines were generated from E12.5-14.5 embryos according to the 3T3 
protocol in 10% bovine calf serum (Aaronson and Todaro, 1968) and maintained in the same 
manner.  Previously published NF-κB luciferase reporter plasmids (Fujita et al., 1992) were 
transfected together with ß-actin-lacZ control plasmid into subconfluent fibroblasts using Ca-PO4 
or fugene6 (Roche) methodologies.  After 24hrs, cells were starved for 24hrs with 0.5% serum 
containing medium and then stimulated with 10ng/ml TNFα. 
 
DNA-binding assays and Western blot 
For whole cell Western blots, cells were lysed within 6 well plates using SDS-PAGE sample 
buffer, and probed with specific antibodies from Santa-Cruz Biotechnology, Inc.  For EMSA, 
previously described methods and κB-site containing probes were used (Fujita et al., 1992; 
Hoffmann et al., 2002).  Supershift assays were done with antibody cocktails specific to indicated 
RHD proteins composed of rabbit antibodies available at Santa Cruz Biotechnology.  The 
reactivity and specificity of these is demonstrated in the data shown in Fig. #3A-D. 
 
RNAse protection assays 
Total RNA was made from confluent and starved fibroblasts using Tri-Reagent (Molecular 
Research Center, Inc).  RNase Protection Analysis was performed with 5µg RNA using Riboquant 
probe sets (Pharmingen) according to manufacturer’s instructions.  Data was quantitated using a 
Molecular Dynamics Phorphorimager.  Following local background subtraction, data was 
normalized using GAPDH and L32 gene data, which allowed results to be compared across 
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experiments.  Every experiment was performed at least twice, many 3 to 5 times with high 
reproducibility. 
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FIGURE LEGENDS 
 
Fig. #1  RHD proteins in NF-κB knockout cells.   
Western blots of cells derived from wild-type, nfκB1-/-, relA-/- and nfκB1-/-/relA-/- mouse embryos 
with antibodies directed against p50, p52, p65, cRel, RelB, and actin (A), and IκBε, -ß, -α, and 
actin (B) as indicated.  Specific bands are shown, but additional bands were detectable with some 
antibodies. 
 
Fig. #2  TNFα induction of κB-binding activity in NF-κB knockout cells. 
Electrophoretic mobility shift assay (EMSA) was used to monitor nuclear NF-κB in wild type (A), 
nfκB1-/- (C), relA-/- (E) and nfκB1-/-relA-/- (G) cells in the indicated (in minutes and hours) 
timecourse following the onset of TNFα stimulation.  The cytoplasmic portion from wild type (B), 
nfκB1-/- (D), relA-/- (F) was probed in Western blots to monitor concurrent degradation and 
synthesis of IκB proteins, IκBα and IκBß (bottom panels), and IκBε (top panels). 
  
Fig. #3  Molecular composition of κB-binding activity in NF-κB knockout cells.  
Immediate early protein-DNA complexes induced by TNFα in wild type (A), nfκB1-/- (B), relA-/- 
(C) and nfκB1-/-relA-/- (D) cells and detected by EMSA in Figure 2 are indicated by arrows in lanes 
1, while constitutive complexes are indicated by asterisks.  They are specific for κB-sites as shown 
by competition with double stranded wild type and mutant oligonucleotides (lanes 2 and 3) and are 
probed with antibodies directed against the indicated RHD proteins (lanes 4-9).  This results in 
“supershift” or ablation of the characteristic protein-DNA complex.  We conclude that the κB-
binding activity in wild type cells consists of p50:p65 heterodimer and p65 homodimer, in nfκB1-/- 
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cells p52:p65 heterodimer and p65 homodimer, in rela-/- cells p50 homodimer, cRel:p50 
heterodimer, and most likely, but not unambiguously cRel homodimer.    While experiments 
shown in panels A, B, C are exposed to film for 6 hrs, panel D shows a 24hr exposure. 
  
Fig. #4  Compensation on different κB-site sequences in extra-chromosomal plasmids. 
Reporter plasmids driven by the c-fos core promoter alone or fused to two κB sites derived from 
the Igκ the MHC H2, and IFNß promoter, as indicated in (A), were assayed in response to TNFα 
stimulation for the indicated time in wild type (red bars), nfκB1-/- (green bars), relA-/- (blue bars) 
and nfκB1-/-relA-/- (black bars).  EMSA (B) was used to monitor κB-binding activity in TNFα 
stimulated NF-κB knockout cells with indicated κB-site containing double-stranded oligo 
nucleotide probes.  Induced, specific bands are indicated by arrows, a prominent constitutive 
protein-DNA complex is indicated by an asterisk. 
 
Table 1.  RHD proteins induced by TNFα stimulation in NF-κB knockout cells.   
Fibroblast cell lines derived from embryos of indicated genotypes (column 1) exhibit TNFα 
inducible κB binding activity that consists of indicated RHD proteins (column 2).  These proteins 
form κB-binding complexes indicated in column 3.  All data are based on EMSA with κB-site 
containing probes and antibodies directed against specific RHD proteins.  Complexes marked with 
an asterisk were detected with only a subset of κB-site containing probes. 
 
Fig. # 5  Quantitative monitoring of gene expression by multiplex RNAse protection assay (RPA).   
Multiple double stranded RNA products indicative of mRNA transcripts derived from indicated 
NF-κB-dependent and house keeping genes following TNFα stimulation of wild type fibroblasts 
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resolved by electrophoresis (A). Three independent experiments with independently derived wild 
type 3T3 cell lines were quantitated by phospho-imager and mRNA abundance was graphed for 
the indicated chemokine genes in arbitrary units relative to housekeeping genes L32 and GAPDH 
(B).   
 
Fig. #6  Transcriptional induction by TNFα of NF-κB target genes in NF-κB knockout cells.  
Results from a representative RPA experiment are graphed for the indicated genes in three panels.  
The left panel shows data from wild type (red line) and nfκb1-/-rela-/- cells (black line), the center 
panel from nfκb2-/- (red), nfκb1-/- (green), and nfκb1-/-nfκb2-/- (black), and the right panel from crel-
/- (red), rela-/- (green), and rela-/-crel-/- (black) cells. 
 
Table 2.  Distinct RHD protein requirements for NF-κB-dependent genes. 
Transcriptional regulation results are summarized for each of the ten genes (column 1) monitored: 
Temporal regulation (column 2), expression in indicated knockout cells (columns 3-5), and 
deduced RHD protein requirement (column 6 - 7).   
 
Table 3.  κB-site sequences do not correlate with RHD dimer specificity. 
NF-κB-dependent genes (column 1) are listed in order of increasingly restrictive RHD protein 
dimer requirement (column 2).  Corresponding gene promoters contain conserved κB-sites of 
indicated sequences (column 3) that were show to be functional in previously published studies 
(column 4). 
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CHAPTER 4:   
One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB 
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ABSTRACT 
The transcription factor NF-κB regulates a wide variety of genes involved in multiple processes. 
Although the apparent consensus sequence of DNA-binding sites for NF-κB (κB sites) is very 
broad, the sites active in any one gene show remarkable evolutionary stability. Using a lentivirus 
based methodology for implantation of gene regulatory sequences we show that for genes with two 
κB sites, both are required for activity. Swapping sites between κB -dependent genes altered NF-
κB dimer specificity of the promoters and revealed that two κB sites can function together as a 
module to regulate gene activation. Further, although the sequence of the κB site is important for 
determining κB family member specificity, rather than determining the ability of a particular dimer 
to bind effectively, the sequence affects which co-activators will form productive interactions with 
the bound κB dimer. This suggests that binding sites may impart a specific configuration to bound 
transcription factors. 
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INTRODUCTION 
Study of mammalian gene transcription is often confounded by the recognition of a single 
regulatory sequence by multiple members of a transcription factor family. Expansion of the 
number of members in a particular family may occur over evolutionary time suggesting that 
particular members evolve to serve restricted functions in a complex organism. However, outside 
of the nuclear hormone receptor superfamily (Rastinejad, 2001), little is known about how 
individual family members provide specificity.   
 
NF-κB is a dimeric protein that mediates cellular responses to a wide variety of stimuli including 
TNFα, LPS, IL-1, and ultraviolet light (Ghosh et al., 1998; Karin and Ben-Neriah, 2000; Karin et 
al., 2002). NF-κB plays an integral role in many important and diverse processes, including 
inflammatory responses, immune system development, apoptosis, learning in the brain, and bone 
development. In resting cells, NF-κB is held inactive via associations with inhibitory proteins 
called inhibitors of NF-κB (IκB). When the cell is stimulated, IκB proteins are phosphorylated, 
ubiquitinated, and degraded, allowing NF-κB to bind DNA and activate appropriate target genes.   
 
In response to inflammatory stimuli, four members of the NF-κB family are involved in gene 
activation: p50, p52, p65, and cRel. They are the mature gene products from four genes: nfκB1, 
nfκB2, relA, and cRel respectively, and they homo- or heterodimerize with one another to bind 
DNA. It is noteworthy that mice deficient in a single NF-κB/Rel family member exhibit unique, 
largely non-overlapping phenotypes. For instance, relA-/- animals are embryonic lethal and develop 
massive liver apoptosis (Beg et al., 1995), while nfκB1-/- mice develop normally but have deficits 
in immune function (Sha et al., 1995).  
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Past studies predominantly used transient-transfection reporter systems with over-expressed NF-
κB proteins to conclude that certain κB complexes bind particular NF-κB binding sites (called κB 
sites) preferentially (Fujita et al., 1992; Kunsch et al., 1992). When similar transient-transfection 
reporter assays were repeated in NF-κB knockout cells, NF-κB family members exhibited no 
preference for particular κB sequences (Hoffmann et al., 2003). With increased knowledge about 
transcriptional regulation, questions about the recruitment of specific NF-κB family members to a 
promoter should be addressed within a physiological context. 
 
Our previous study utilized a genetic approach to study NF-κB-dependent gene activation by 
creating a panel of single and double NF-κB knockout cell lines (Hoffmann et al., 2003). We 
showed there that TNFα-stimulated, κB-dependent genes may require specific κB family members 
for activation. Some genes had stricter requirements than others. For example, any p65 or cRel-
containing hetero- or homodimer could activate the MCP-1 gene, while the LIF gene specifically 
required a p50:p65 heterodimer for activation. We were unable to document a strict correlation 
between κB family member requirements and their κB site sequences. 
 
Structural studies have also not revealed evidence for highly specific interactions between NF-κB 
and its cognate DNA-binding sites.  κB sites display a remarkably loose consensus sequence, often 
cited as G-5G-4G-3R-2N-1N0Y+1Y+1C+2C+3 (Ghosh et al., 1998). Crystal structures have shown that 
p50 homodimers often interact specifically with 5’-G-5G-4G-3, while p65 homodimers interact 
specifically with 5’-G-5G-4. X-ray structures of p50:p65 heterodimers demonstrate that they can 
bind to a variety of κB site sequences (Berkowitz et al., 2002; Chen and Ghosh, 1999; Chen-Park 
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et al., 2002; Escalante et al., 2002). Taken together, structural studies have not identified enough 
dimer-specific DNA-binding contacts to rationalize specific NF-κB binding sites and underscore 
the remarkable permissiveness in NF-κB-DNA interactions. 
 
In this study, we demonstrate that the sequence of the κB site does play an important role in 
determining κB family member specificity. But rather than the site determining the ability of a 
particular dimer to bind effectively, we find that the sequence of the κB site affects which co-
activators will form productive interactions with the bound κB dimer, suggesting that binding sites 
may affect the configuration of the bound dimer. 
 
RESULTS 
κB site sequences are strictly conserved between mouse and human 
To understand whether the sequences of κB sites play a significant role in determining functional 
specificity, validated mouse and human κB site sequences for eleven κB-dependent genes were 
compared using the Celera and Ensembl databases (Hoffmann et al., 2003; Libermann and 
Baltimore, 1990; Thanos and Maniatis, 1995b). The κB site sequences for all eleven genes studied 
were 100% conserved between mouse and human (Figure 1A).  In contrast, a pairwise sequence 
comparison program (Family Relations) revealed that the regions surrounding the κB sites often 
displayed <85% conservation (data not shown) (Brown et al., 2002). If the sequence of the κB site 
did not play a significant role in determining functional specificity, we would have expected the 
sequence of some of the κB sites to mutate over time. We therefore decided to test whether the 
sequence of the κB site can alter the functional properties of bound dimers. 
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To address the role of κB site sequence, we wanted to swap the sequences between two κB-
dependent genes with different properties. The IP-10 and MCP-1 genes were chosen for 
investigation. When IP-10 and MCP-1 respond to TNF, they have different κB family member 
requirements. MCP-1 is induced in both wild type (WT) and p50/p52 deficient cells, while IP-10 is 
induced in WT cells but not p50/p52 deficient cells (Hoffmann et al., 2003). p65 homodimers are 
the only detectable dimer in p50/p52 deficient 3T3 cells. Therefore, both hetero- and homodimers 
of NF-κB are able to function on the MCP-1 promoter while only heterodimers of NF-κB appear 
able to activate IP-10. The regulatory sequences of the genes have certain similarities but 
significant differences. Based on previous work as well as mouse/human sequence comparisons, 
MCP-1 and IP-10 each appear to have two functioning κB sites that are both required for gene 
activation (Ohmori and Hamilton, 1993; Ohmori and Hamilton, 1995; Ping et al., 1999). Both 
genes are highly expressed in fibroblasts and are responsive to multiple stimuli. However, the 
promoter architecture for the two genes is strikingly different. IP-10’s κB sites are less than 200bp 
from the transcription start site while MCP-1’s functional κB sites are more than 2.3kb away from 
the transcription start site. (MCP-1 has another apparent site near the promoter, which was shown 
to be non-functional and not conserved between mouse and human.) IRF-3 has been shown to be 
important in IP-10 gene regulation but not for MCP-1 (Sakaguchi et al., 2003). The κB site 
sequences are not dramatically different between MCP-1 and IP-10. All sites are 10bp long. The 
distal sites differ in one base pair, and the proximal sites differ in two base pairs (Figure1A).  
 
Lentiviral-based reporter system recapitulates endogenous gene regulation 
To effect the sequence interchanges, we needed a system that would allow us easy access for 
nucleotide alteration but would retain the regulatory properties of the endogenous gene promoters. 
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The use of a retrovirus vector allows insertion of up to 7kb of regulatory information and permits 
sequence alteration at will. We chose a self-inactivating lentiviral vector system that infects both 
dividing and non-dividing cells (Lois et al., 2002). The self-inactivating characteristic involves 
deletion of the virus’s own promoter, ensuring that the inserted regulatory sequence is the only 
such information in the vector. We used a luciferase reporter gene to monitor transcriptional 
activity.  
 
To test the reporter system, we cloned 5kb of the mouse MCP-1 gene promoter into the lentiviral 
construct. (We designate this ML M1M2, denoting its origin from the MCP-1 gene, its use of a 
luciferase reporter gene, and its two κB sites containing MCP-1-derived sequence). Lentiviral 
stocks were prepared, concentrated by ultracentrifugation, and applied to either wild type (WT) 
mouse 3T3 cells or 3T3 cells lacking both p50 and p65 subunits (effectively NF-κB-null cells 
(Hoffmann et al., 2003)). Routinely, multiple cell populations were created by infecting cells with 
serial dilutions of virus. Populations that expressed low basal luciferase activity (roughly 5-fold 
above background) were used for analysis to ensure a low number of integrated proviruses per cell. 
 
WT and p50/p65 deficient cells with the integrated ML transgene were stimulated with TNFα 
(Figure 1B) over a 4 hour time course. WT cells responded robustly, while p50/p65 deficient cells 
had minimal inducible luciferase activity, showing that the system recapitulates the NF-κB 
dependence shown previously for the in situ gene. Next, the κB sites within the MCP-1 promoter 
were mutated to null κB site sequences (ML N1N2). WT cells carrying the integrated ML N1N2 
transgene showed no inducible luciferase activity following TNFα treatment (Figure 1C). Finally, 
two different constructs were created with one κB site left intact and the other κB site mutated to a 
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null sequence (ML M1N2 and ML N1M2) (Figure 1D). As previously shown (Ping et al., 1999), 
the mutation of either κB site to a null sequence abrogated inducible luciferase activity in WT 
cells.  These transgenic cells lines were also stimulated with LPS, and the results were similar to 
those with TNFα (data not shown).  Thus the ML M1M2 transgene is inducible by multiple stimuli 
in a κB-dependent fashion, and both κB sites must be intact for the promoter to be functional. 
 
Swapping MCP-1 κB site sequences for IP-10 κB site sequences imposes IP-10 κB family 
member requirements on the MCP-1 promoter 
The κB site sequences from the IP-10 promoter were swapped into the MCP-1 transgene by PCR 
to create ML I1I2.  WT cells infected with ML I1I2 were responsive to TNFα stimulation, but 
TNFαstimulated, ML I1I2-infected, p50/p52 deficient cells displayed no inducible luciferase 
activity (Figure 2A, right panel). In contrast, p50/p52 deficient cells infected with ML M1M2 
displayed inducible luciferase activity comparable to that of WT cells (Figure 2A, left panel). We 
conclude that the ML I1I2 transgene requires NF-κB heterodimers for activation. 
 
To test whether the altered κB family member requirements in ML I1I2 were dependent on one or 
both of the IP-10 κB site sequences, two MCP-1 promoter constructs were created carrying one IP-
10 κB site and one MCP-1 κB site (ML M1I2, ML I1M2, Figure 2B). Both WT and p50/p52 
deficient cells carrying these constructs remained responsive to TNFα stimulation. Therefore, 
either MCP-1 sequence alone is sufficient to provide a response to the p65 homodimer.   
 
To determine if one or both of the IP-10 κB site sequences were unresponsive to the homodimer, 
two different MCP-1 promoter constructs containing duplicated IP-10 κB site sequences were 
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made (ML I1I1, ML I2I2, Figure 2C). WT cells infected with either ML transgene remained 
responsive to TNFα stimulation. However, p50/p52 deficient cells carrying the ML I1I1 transgene 
were not responsive to TNFα stimulation, while those carrying the ML I2I2 transgene displayed 
inducible luciferase activity. Thus, the I1 or distal κB site of the IP-10 promoter determines the 
heterodimer requirement of the IP-10 promoter.  The κB site sequences in the ML I1I1 construct 
differ from those in the ML M1M2 construct only at the sixth nucleotide for each site. Therefore, 
we can identify this single nucleotide as responsible for the difference in κB family member 
requirements.   
 
To exclude the possibility that nearby factors bound to the MCP-1 promoter may affect κB-dimer 
specificity, lentiviral constructs containing only the c-fos minimum promoter and the κB sites from 
MCP-1 or IP-10 were tested. Upon TNFα treatment, the construct containing the MCP-1 κB sites 
was responsive to hetero- and homodimers of NF-κB, while the construct containing IP-10 κB 
sites only responded to heterodimers of NF-κB (data not shown). 
 
p65 and CBP are bound to the inactive ML I1I2 transgene in TNFαstimulated  
p50/p52 deficient cells 
One possible explanation of the inability of the IP-10 distal κB site to respond to a homodimer of 
p65 would be an inability of the site to bind the homodimers. To address this possibility, we 
performed chromatin immunoprecipitation (ChIP) assays with an anti-p65 antibody in TNFα-
stimulated WT and p50/p52 deficient cells containing the ML I1I2 transgene. WT cells with the 
ML I1I2 transgene showed robust p65 binding after TNFα stimulation (Figure 3A).  Surprisingly, 
p50/p52 deficient cells with the ML I1I2 transgene also demonstrated p65 binding after TNFα 
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stimulation. Therefore, even though the ML I1I2 transgene shows minimal activity in TNFα 
stimulated p50/p52 deficient cells, p65 homodimers are still bound to the promoter. Examination 
of the endogenous IP-10 promoter gave a congruent result. In TNFα-stimulated p50/p52 deficient 
cells, p65 was still bound to an inactive IP-10 promoter (Figure 3B).   
 
If p65 homodimers are bound to an inactive ML I1I2 transgene, the κB site sequence might not 
support transcription because the conformation of the p65 homodimers might not recruit the 
appropriate co-activators to the promoter. One type of co-activator known to interact with the 
transactivation domain of p65 is CBP/p300 (Perkins et al., 1997; Sheppard et al., 1999). We 
performed ChIP assays against p300 using TNFα-stimulated, ML M1M2-infected, p50/p52 
deficient cells and discovered that p300 is recruited to the MCP-1 and IP-10 promoters in a 
stimulus-dependent manner (Figure 3C). Furthermore, we found that p300 was bound to the ML 
I1I2 transgene in TNFα stimulated p50/p52 deficient cells (Figure 3D). Thus, this co-factor is 
recruited even though the promoter is not firing. 
 
IP-10 displays stimulus-specific requirements for NF-κB family members 
To test whether the IP-10 gene shows the same heterodimer requirement to an inducer other than 
TNFα, WT and p50/p52 deficient cells were stimulated with TNFα or LPS over a 6 hour time 
course, and IP-10 induction was assayed by quantitative PCR (Q-PCR). The induction of IP-10 in 
TNFαstimulated WT and p50/p52 deficient cells recapitulated our previously published 
ribonuclease protection assays showing the heterodimer requirement for activation (Figure 4A, left 
panel). In contrast, LPS-stimulated WT and p50/p52 deficient cells induced IP-10 to similar levels 
(Figure 4A, right panel). Thus the heterodimer requirement is an inducer-specific phenomenon.  
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To determine if the lentiviral-based reporter system could recapitulate IP-10’s stimulus-specificity, 
1kb of the IP-10 promoter was cloned into our retrovirus vector (IL). Consistent with the whole 
cell data, TNFα-stimulated WT cells with the integrated IL transgene displayed induced luciferase 
activity, while p50/p52 deficient cells with the IL transgene showed significantly lower activity 
(Figure 4B, left panel). In contrast, LPS-stimulated WT and p50/p52 deficient cells with the IL 
transgene demonstrated similar luciferase activity (Figure 4B, right panel). Thus, the lentiviral 
system recapitulated the stimulus-specific behavior of the endogenous IP-10 gene. 
 
To be certain that the stimulus-specificity was determined by the κB site, we went back to the 
chimeric transgenes. In fact, as opposed to the data with TNFα-stimulated cells, LPS-treated WT 
and p50/p52 deficient cells containing the ML I1I2 transgene displayed similar levels of luciferase 
induction (Figure 4C, right panel). Studies with the ML I1I1 transgene demonstrated similar results 
(data not shown) and supported the conclusion that p65 homodimers are bound to the I1 site.  
Taken together, these results confirmed that the stimulus-specificity was a consequence of the κB 
site sequence and was consistent with the observation of p65 homodimers on the ML I1I2 
transgene.  It strongly suggested that the unresponsiveness of the IP-10 gene to homodimers in the 
TNFαtreated cells is a consequence of the lack of a co-factor that LPS can induce. 
 
Overexpression of IRF-3 rescues induction of ML I1I2 transgene by TNFα 
To identify the LPS-specific factor that allows κB homodimers to activate the ML I1I2 transgene, 
we noted that LPS signals through the TLR-4 receptor (Akira, 2003; Takeda et al., 2003). TLR-4 
downstream signaling is divided into two distinct pathways, one mediated by Myd88 and the other 
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by Trif. Since IP-10 is induced by LPS in Myd88 knockout fibroblasts (Yamamoto et al., 2002), 
we focused on signaling molecules in the Trif-dependent pathway. IRF-3 is a transcription factor 
induced in the Trif-dependent pathway and has been shown to play a role in IP-10 induction by 
LPS (Sakaguchi et al., 2003; Yamamoto et al., 2003). Furthermore, an interaction between IRF-3 
and p65 has been demonstrated (Wietek et al., 2003). 
 
A retrovirus expressing the IRF-3 cDNA was created and used to infect WT and p50/p52 deficient 
cells. Overexpression of IRF-3 protein was confirmed by Western analysis (Figure 5A, left panel). 
IRF-3 overexpressing cells were then infected with the ML I1I2 transgene and stimulated with 
TNFα over a 6 hour time course. Overexpression of IRF-3 rescued the induction of the ML I1I2 
transgene in p50/p52 deficient cells (Figure 5A, right panel). This result also supports the 
interpretation of the ChIP data that p65 was bound to the identified functional κB sites and not 
cryptic elements. 
 
Since the MCP-1 promoter does not contain an IRF-3 binding site, it seemed likely that IRF-3 is 
serving as a co-activator in this situation. Previous work has shown that the c-myc transcription 
factor can bind and activate a number of promoters, which contain no apparent c-myc binding sites 
(Li et al., 2003).  To test this hypothesis, an expression vector containing IRF-3 with its DNA-
binding domain deleted was created (IRF-3∆DBD). Expression of IRF-3 ∆DBD in WT and 
p50/p52 deficient cells was confirmed by Western analysis (Figure 5B, left panel). The IRF-3 
∆DBD cells were then infected with the ML I1I2 transgene and stimulated with TNFα over a 6 
hour time course. Expression of IRF-3 ∆DBD rescued the induction of the ML I1I2 transgene in 
p50/p52 deficient cells (Figure 5B, right panel). 
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To confirm that IRF-3 is required for LPS stimulation of the ML I1I2 transgene in p50/p52 
deficient cells, we created a retrovirus expressing an RNAi cassette against IRF-3 (Qin et al., 
2003). IRF-3 protein levels were confirmed by Western analysis and were knocked down 
approximately 3-4-fold (Figure 5C, left panel). p50/p52 deficient cells with IRF-3 knocked-down 
were infected with the ML I1I2 transgene, stimulated with LPS, and assayed for luciferase 
induction. The absence of IRF-3 in LPS-stimulated p50/p52 deficient cells abrogated the induction 
of the ML I1I2 transgene (Figure 5C, right panel). 
 
As mentioned earlier, endogenous IP-10 requires IRF-3 for gene activation. We have demonstrated 
that the κB site sequence can alter the configuration of bound p65:p65 homodimers to implement 
an IRF-3 requirement for transgene activation. Does the change in κB site sequence alter the 
configuration of all κB dimers such that the ML I1I2 transgene requires IRF-3 for gene activation 
in WT cells, where the major species of NF-κB is p65:p50 heterodimers? Using the same 
retrovirus, we knocked down IRF-3 in WT cells (Figure 5D, left panel). The absence of IRF-3 in 
LPS-stimulated WT cells also abrogated the induction of the ML I1I2 transgene (Figure 5D, right 
panel).  To further confirm these findings, the absence of IRF-3 in TNFα-stimulated WT cells did 
not affect the induction of IP-10 or the ML I1I2 transgene (data not shown). 
 
IRF-3 is recruited to I1I2 κB-binding sites 
To test whether IRF-3 is directly recruited to the ML I1I2 transgene, ChIP assays were performed 
with an anti-IRF-3 antibody in LPS-stimulated, IRF-3 overexpressing, WT cells. We found that 
IRF-3 was bound to the IP-10 promoter but not the MCP-1 promoter in a LPS-dependent manner 
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(Figure 5E, left panel). Furthermore, IRF-3 was also bound to the ML I1I2 transgene (Figure 5E, 
right panel). Therefore, IP-10’s κB site sequences are able to recruit IRF-3 to a promoter. 
 
IP-10’s requirement for IRF-3 in p50:p52 deficient cells can explain the stimulus-specific 
requirements for κB family members. Under LPS stimulation, p65 homodimers appear to interact 
with IRF-3 to activate the ML I1I2 transgene. Under TNFα stimulation, IRF-3 is not activated and 
the p65 homodimers, although bound, are unable to function and the ML I1I2 transgene is not 
activated. For LPS stimulated WT cells, we demonstrated that p65:p50 heterodimers appear to 
interact with IRF-3 to activate the ML I1I2 transgene. This result implies that the κB site sequence 
can change the configuration of heterodimers, not just p65 homodimers. Finally, we show that 
IRF-3 is directly recruited to the ML I1I2 promoter in a stimulus-dependent manner. 
 
IP-10 requires Bcl-3 for Induction by TNFα 
The need for IRF-3 provides an explanation for the stimulus specificity in p50/p52 deficient cells. 
But we see no such specificity in WT cells. Why not? Might there be another co-activator that 
suffices in WT cells where the p65:p50 heterodimer predominates? We were drawn to the 
observation that Bcl-3, an IκB-like protein that interacts preferably with p50 or p52, can serve as a 
co-activator (Franzoso et al., 1992; Fujita et al., 1993).   
 
To examine the possibility that Bcl-3 is critical to IP-10 induction in WT cells, Bcl-3-deficient 
cells were stimulated with TNFα over a 4 hour time course. RNA transcript levels of endogenous 
IP-10 and MCP-1 were measured by Q-PCR. IP-10 induction was absent in Bcl-3 deficient cells, 
while MCP-1 induction recapitulated WT levels (Figure 6A). Thus, in TNFα-stimulated cells, IP-
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10 is a Bcl-3 dependent gene. As expected, when Bcl-3 deficient cells were infected with the ML 
I1I2 transgene and stimulated with TNFα over a 4 hour time course, minimal luciferase induction 
was observed, showing that the Bcl-3 dependence is a consequence of the κB site sequence (Figure 
6B, left panel). In contrast, the ML M1M2 transgene was induced to similar levels in WT and Bcl-
3 deficient cells (Figure 6B, right panel).  Finally, induction of IP-10 expression in LPS-stimulated 
Bcl-3 deficient cells remained intact (data not shown). 
 
DISCUSSION 
In our previous study, no direct correlation between the κB site sequence and κB family member 
requirements for gene activation could be found (Hoffmann et al., 2003). There we compared one 
gene to another but when, in this study, we made interspecies comparisons of the same gene, we 
found a remarkable constancy of sequence, implying that the individual sequences have important 
characteristics. This led us to examine the role of the particular sequences found associated with 
particular genes. To do this we developed a lentiviral system for incorporating regulatory 
sequences into cellular DNA. Then, by swapping the κB site sequences within the MCP-1 
promoter to the κB site sequences for the IP-10 gene, we found that we could impose IP-10’s κB 
family member requirements onto the MCP-1 promoter. Both IP-10 κB site sequences had to be 
transferred to change κB family member requirements and revealed that two κB sites can function 
together as a module to regulate gene activation. This suggested that either MCP-1 site was 
dominant over the two IP-10 sites. By doing chromatin immunoprecipitation experiments, we 
found that even though the I1 site would not work with the p65 homodimer, the IP-10 κB sites did 
bind the homodimer which, in turn, even bound the co-activator CBP/p300. We then found that the 
IP-10 requirement for a κB heterodimer for activation by TNFα is not evident after LPS 
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stimulation. This suggested that the κB site specificity operated by imposing on the DNA-bound 
NF-κB a co-factor requirement for activation. In fact, we showed that the ML I1I2 transgene 
requires Bcl-3 when stimulated by TNFα and that IRF-3 can play this role in p50/p52 deficient 
cells where Bcl-3 is not able to function. Because IRF-3 is induced by LPS but not TNFα, the role 
of this κB site specificity is explained. We extended the analysis to show that the IRF-3 
requirement for LPS-stimulated ML I1I2 transgene activity applies to p50:p65 heterodimers as 
well.  Therefore, the κB site sequence affects the configuration of both heterodimers and p65 
homodimers. Finally, we showed that IRF-3 is recruited to the ML I1I2 promoter.  The sequence 
alteration that imposes the co-activator requirement is a single nucleotide in the sixth position of 
the κB site—it is quite remarkable that such a change can impose on a gene a new co-factor 
requirement that is fulfilled only under particular circumstances. 
 
How is specificity imposed? 
There are three models for how the single nucleotide difference in the κB site can impose such 
specificity. One model suggests that there is another protein bound to the DNA site that requires 
this particular nucleotide. It would most likely bind in conjunction with NF-κB, just as HMG I(Y) 
has been shown to bind to certain κB sites along with NF-κB (Falvo et al., 1995). The factor would 
bind the distal IP-10 site because that site dominantly imposes the heterodimer restriction. It seems 
a bit far-fetched but not impossible that a protein could bind to the κB site and then dominantly 
impose a restriction on the functioning of a dimer that would be overcome by a co-factor. IRF-3 
and Bcl-3 would be the responsible co-factors in LPS- and TNFα-stimulated cells respectively.   
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Another possibility is that κB dimers may oligomerize when bound to their respective sites. The 
sequence of the κB site would determine oligomerization efficiency and precise conformation of 
the overall structure. The κB tetramer would determine which co-factors would be needed for gene 
activation.    
 
A likely possibility is that the particular distal IP-10 κB site imposes a configuration on the bound 
heterodimers that establishes a requirement for Bcl-3. In the p50/p52 deficient cells, where Bcl-3 
cannot bind the p65 homodimers, the requirement for a co-activator can be supplied by IRF-3, 
which can bind to p65 (Wietek et al., 2003). 
 
Potential model 
To fully explain our data, we return to the observation that two κB sites are needed for the MCP-1 
promoter to function. The stimulus and subunit specificities have been explained by the role of one 
κB site, but why then do we need two? We suspect that the two sites serve different and non-
redundant roles. This postulate leads us to a model that the two κB sites serve different and jointly 
obligate functions.   
 
In LPS-stimulated p50/p52 deficient cells infected with the ML M1M2 transgene, we know that 
p65 homodimers are bound to the κB sites along with p300/CBP (data not shown), and drive 
luciferase expression. Our postulate that the two sites serve different functions leads us to suppose 
that only one κB homodimer binds p300 and that the other binds an unknown factor X but other 
explanations are conceivable (Figure 7A). In LPS-stimulated p50/p52 deficient cells infected with 
the ML I1I2 transgene, we postulate that the I2 site continues to bind p300/CBP but the I1 κB site 
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sequence alters the p65 homodimer conformation such that another co-factor must take the place of 
X. IRF-3 can serve this function and in LPS-induced cells, it binds and cooperates to drive 
luciferase expression (Figure 7B). In TNFα-stimulated p50/p52 deficient cells with the ML M1M2 
transgene, the situation is similar to that in LPS-simulated cells (Figure 7C). However, in the 
TNFα-stimulated p50/p52 deficient cells with the ML I1I2 transgene, the change in the I1 κB site 
sequence alters the conformation for p65 homodimers such that they require a co-factor of a type 
that is simply not present in the cells. Instead, only κB heterodimers are able to drive transcription 
because of the requirement for the second activity is supplied by Bcl-3 binding to the p50 subunit 
(Figure 7D).   
 
Advantages of a retrovirus-based reporter system 
Our retrovirus-based lentiviral reporter system is a novel approach to study gene transcription. This 
system offers many advantages over current transcription reporter systems. 1. The promoter of the 
gene of interest is integrated into the cell’s DNA and should therefore be subject to chromatin 
regulation. 2. Tandem copies of integration are avoided to allow for faithful promoter regulation. 3. 
Copy number of the transgene can be controlled. 4. This system can be applied to non-dividing and 
untransfectable cells. 5. Most importantly, the system allows flexibility to conveniently modify 
promoter sequence by PCR. A limitation of this system is the amount of DNA sequence one can 
place into the vector (roughly 7kB). In truth, it is not possible to know for sure how much 
regulatory DNA a particular gene requires so the optimum method for studying promoters would 
be to make nucleotide changes in situ in the promoter regulatory elements using “knock-in” 
technology (Xu et al., 1996). Unfortunately, “knock-in” or even BAC transgene experiments (Lee 
et al., 2003) are difficult, time-consuming and prohibitively expensive as a method to do a 
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systematic study, such as we have presented here. Our approach represents an effective 
compromise between the ideal and need for extensive experimental manipulation.  
 
κB site sequence determines NF-κB family member requirements 
In our previous study, we documented that κB-dependent genes require specific κB family 
members for functional activation (Hoffmann et al., 2003). Here, we demonstrate that the sequence 
of the κB site is responsible for determining NF-κB dimer specificity, and two κB binding sites 
can function together to regulate gene activation.  This regulation does not occur at the level of κB 
dimer exclusion. In fact, we found inducible p65 recruitment to a functionally inactive promoter. 
Instead, we believe that the sequence of the κB site contains information that is interpreted by the 
bound κB dimer, changes the κB dimer configuration, and determines which co-activators will 
form functional interactions with the κB dimer.   
 
How many functionally different κB sites might there be? We can presently identify three different 
types. M1 or M2 are sites that, as far as we can determine are identical and which we postulate 
bind factor “X.” A key property of this class of κB site is that it is dominant over other sites. The 
second class is I1, a site that requires IRF-3 or Bcl-3 co-activators for activation when it is coupled 
to I2 or is used in tandem. I1 differs from M1 and M2 at only one position, nucleotide 6. Finally, 
the I2 site is in a category by itself. It must require a co-activator different from M1 or M2 that is 
not dominant over I1. It is notable that I2 has two nucleotides, at positions 5 and 8, different from 
both M2 and I1. There is every reason to expect that there are other κB sites with specificities yet 
to be identified. From our limited evolutionary survey in Figure 1A, we see 12 different sites all of 
which are conserved between mouse and human. It could be that these 12 and others are all serving 
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specific functions, going a long way to providing the breadth of diversity needed to understand 
how κB sites can be found in so many different genes which are regulated in specific ways 
(Hoffmann et al., 2003).   
 
κB site sequence determines co-activator requirements 
It is impressive that changing one base pair would have such a dramatic effect on gene regulation. 
However, recent structural studies support this conclusion. Comparisons of p50:p65 dimers bound 
to different κB sites sequences have revealed significant differences in their conformation (Chen-
Park et al., 2002). These differences in conformation have been correlated to their ability to 
transactivate transfected reporter plasmids. Therefore, our notion that it is co-activator binding 
which determines specificity is supported by prior structural studies showing alternate 
conformations induced allosterically by different DNA-binding site sequences.  
 
In other families of transcription factors, there is also evidence that DNA can act as an allosteric 
regulator. It has been best-studied with the glucocorticoid receptor (GR) (Lefstin and Yamamoto, 
1998).  The DNA-binding domain of GR can bind its cognate site in a variety of conformations 
depending on the sequence of the site, serving to present different interfaces for the recruitment of 
specific co-factors and to help determine whether the bound factor will activate or repress 
transcription. Recent work has identified which GR surfaces are required in a gene-specific manner 
(Rogatsky et al., 2002; Rogatsky et al., 2003). Similar findings have also been reported for the 
POU family of proteins (Phillips and Luisi, 2000). 
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The prevailing model of gene transcription is that on a given promoter multiple proteins must 
interact, assemble, and form an enhanceosome to activate gene transcription (Thanos and Maniatis, 
1995b). If one factor is absent, the gene is not activated. Numerous examples of NF-κB’s role in 
this model exist, most notably on the HIV-LTR, IFNß, and IL-2 promoters (Perkins et al., 1994; 
Perkins et al., 1993; Rothenberg and Ward, 1996; Thanos and Maniatis, 1995b). Furthermore, 
chromatin has also been implicated as having a role in determining NF-κB’s access to DNA-
binding sites and may do so in a κB dimer-specific fashion (Saccani et al., 2001; Saccani et al., 
2003).  In the best-studied system, the IFNß gene, there is only one κB site and that is why it may 
be so complex. In vitro binding and transient transfection studies demonstrated that the κB site 
sequence is important, presumably to coordinate the binding of both NF-κB and HMG (I)Y 
(Thanos and Maniatis, 1995a). As we imply by the models in Figure 7, where there are two κB 
sites, the situation may be different because there can be two interacting complexes formed around 
two NF-κB dimers. 
 
Bcl-3 requirement 
TNFα activation of IP-10 activation requires Bcl-3, and our data implies that p50:p65 heterodimers 
interact with Bcl-3. Previous studies have shown that Bcl-3 preferentially interacts with p50 or p52 
homodimers and not with p50:p65 heterodimers (Franzoso et al., 1992; Fujita et al., 1993). We can 
suggest three potential mechanisms to explain this apparent discrepancy. First, even though the 
major constituent of NF-κB in wild type fibroblasts is p50:p65 heterodimers, a significant amount 
of p50:p50 homodimers exist and could bind one of the two sites to interact with Bcl-3 to activate 
IP-10. Second, it may be possible that p50:p65 heterodimers can interact with Bcl-3 to activate IP-
10 expression. Third, as mentioned earlier, p50:p65 heterodimers may oligomerize when bound to 
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their respective sites. The p50 subunits from each heterodimer could conceivably interact and 
recruit Bcl-3, 
 
Biology 
MCP-1 and IP-10 are differentially regulated, presumably because they serve different functions. 
MCP-1 plays a significant role in innate immunity by bringing macrophages to sites of 
inflammation. On the other hand, IP-10 is important for lymphocytic (adaptive) immunity and 
regulates T cell proliferation. MCP-1 is also activated by a more diverse set of TLR agonists than 
IP-10. For example, TLR-2 agonists stimulate MCP-1, but not IP-10 expression (Pierer et al., 
2004; Re and Strominger, 2001). Recent studies reveal that MCP-1 and IP-10 are regulated 
differently during TLR-4 stimulation (Sakaguchi et al., 2003; Serbina et al., 2003; Yamamoto et 
al., 2003). IP-10 is activated through TLR-4 via a Trif dependent pathway. The Trif dependent 
pathway activates the interferon-response pathway and is responsible for a late NF-κB activation 
(Yamamoto et al., 2003). It has been shown that this pathway regulates a specific subset of 
TLR3/TLR4 dependent genes, and that the pathway is evolutionarily diverged from other members 
of the TLR family (Doyle et al., 2002). In contrast, MCP-1 is activated by both the MyD88-
dependent and Trif-dependent pathways. The Myd88 pathway differs from the Trif pathway in two 
ways.  First, it does not activate the interferon-response pathway. Second, it activates NF-κB much 
earlier than the Trif pathway. 
 
These two pathways normally work together to ready an immune response to a bacterial pathogen. 
A bacterial pathogen would signal the TLR-4 receptor and activate both downstream pathways. 
The Myd88 pathway would activate NF-κB immediately to drive MCP-1 production and recruit 
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macrophages to the target site. Later, the Trif pathway would activate both the NF-κB and IRF-3 
pathways to drive IP-10 production and regulate T cell proliferation. By simply changing the 
sequence of κB sites in the MCP-1 promoter, we converted MCP-1’s regulation profile into IP-
10’s. We speculate that in a mouse this would severely disrupt the delicate balance between innate 
and adaptive immunity. Our results underscore the functional importance of the sequence of the κB 
site and confirm why the sequence of κB sites is strictly conserved over time. Not only does the κB 
site sequence determine κB dimer specificity, it also determines co-activator requirements. 
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MATERIALS AND METHODS 
 
Cell culture and Time Courses 
Immortalized cell lines were generated and maintained as previous described (Hoffmann et al., 
2003).  100% confluent cells were treated for 48 hours with 0.5% serum containing medium and 
then stimulated with the appropriate concentration of TNFα or LPS over a period of 4-6 hours. 
 
Plasmids 
To generate ML M1M2, 5kB of the MCP-1 promoter was amplified by PCR from a BAC clone. 
The resulting fragment was cloned into FugW (Lois et al., 2002). To generate IL, 967bp of IP-10 
promoter (-939 - +28) was amplified by PCR and cloned into FugW. Variations of ML plasmid 
were constructed by PCR mutagenesis. IRF-3 and IRF-3 ∆DBD expression plasmids were 
generated by amplifying IRF-3 (amino acids 1-420) and IRF-3 ∆DBD (133-420) by PCR and 
cloning into the pBABE-neo vector (Morgenstern and Land, 1990). All plasmids were verified by 
DNA sequencing and restriction digest analysis. 
 
Real Time PCR 
Total RNA was made from confluent and starved fibroblasts using TriReagent (Molecular 
Research Center, Inc.). cDNA was synthesized with Superscript II (Invitrogen) following 
manufacturer’s guidelines and 100ng total RNA as a starting amount. Q-PCR was performed using 
Sybr Green PCR Master Mix (Applied Biosystems) and a 5600 Real Time PCR machine (Applied 
Biosystems). Samples were performed in triplicates, and GAPDH transcript levels were used to 
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normalize between samples. Every experiment was performed at least twice, many three-six times 
with high reproducibility. Primer sequences are available upon request. 
 
Reporter Assay 
Luciferase assay was performed as described elsewhere (Pomerantz and Baltimore, 1999).  
Samples were normalized for protein levels by Bradford assay.  Every experiment was performed 
at least twice, most three-five times with high reproducibility. 
 
Chromatin Immunoprecipitation 
ChIP studies were based on a combination of published protocols (Boyd and Farnham, 1999; Boyd 
et al., 1998; Nissen and Yamamoto, 2000; Saccani et al., 2001). p65 and IRF-3 antibodies were 
purchased from Santa Cruz Biotechnologies (sc-109) and Zymed Laboratories respectively. p300 
antibody was a gift from Kevin Gardner. Sequences of promoter-specific primers and our detailed 
protocol are available upon request. 
 
Lentivirus 
Lentivirus was produced as described elsewhere (Lois et al., 2002). 
 
siRNA 
FG12 RNAi vector and production of siRNA was previously described elsewhere (Qin et al., 
2003). The IRF-3-siRNA contains the sense targeting sequence of gacgcacagatggctgact 
corresponding to the 390-407 nucleotide positions of the mouse IRF-3 coding sequence.   
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FIGURE LEGENDS 
 
1.   Functional κB site sequences are strictly conserved and activation of lentiviral MCP-1 trangene 
is responsive to stimuli and dependent on NF-κB 
Validated mouse and human κB site sequences for eleven κB-dependent genes were compared 
using the Celera and Ensembl databases (A).  The κB site sequences for all of the eleven genes 
studied were 100% conserved between mouse and human.  Roughly 5kb of the MCP-1 gene 
promoter and a luciferase reporter gene (ML M1M2) was implanted into wild-type and p50/p65 
knockout 3T3 cells by lentiviral infection. Cells were stimulated with TNFα over a four-hour time 
course. Four variations of the ML transgene are shown: a 5kB wild-type version “ML M1M2” (B), 
a version with both κB binding sites mutated to a null sequence “ML N1N2” (C), a version where 
the distal κB binding site is intact and the proximal site is mutated to a null sequence “ML 
M1N2”(D, left panel), and a version where the distal binding site is mutated to a null sequence and 
the proximal site is intact “ML N1M2” (D, right panel). 
 
2.  Swapping MCP-1 κB site sequences for IP-10 κB site sequences imposes IP-10 κB family 
member requirements on the MCP-1 promoter. 
IP-10 κB site sequences (ML I1I2) were swapped for the MCP-1 κB site sequences in the ML 
transgene by PCR mutagenesis. Lentivirus was produced and applied to wild-type and p50/p52 
knockout 3T3 cells. Panel A compares the activity of the integrated ML M1M2 transgene to the 
ML I1I2 transgene. Panel B shows the activity of the transgene when one MCP-1 κB binding site 
is swapped with its corresponding IP-10 κB binding site sequence (ML M1I2 or ML I1M2). Panel 
C compares the activity of the transgene when either one of the IP-10 κB sites are duplicated and 
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inserted into the transgene (ML I1I1 and ML I2I2). All cells were stimulated with TNFα over a 4 
hour time course. 
 
3.  p65 homodimer and p300/CBP bind to ML I1I2. 
Chromatin immunoprecipitation assays with antibodies against p65 (A, B) and p300 (C, D) 
demonstrate that p65 and p300 binds the MCP-1 promoter, the IP-10 promoter, and ML I1I2 
transgene in a TNFα-dependent manner. The white line indicates where lanes irrelevant to the 
figure have been cropped (B). 
 
4.  IP-10 κB binding sites display stimulus-specific κB family member requirements. 
Wild-type (WT) and p50/p52 knockout cells were stimulated with LPS. IP-10 RNA transcript was 
measured by quantitative PCR (A). 1kb of the IP-10 promoter was cloned into the lentiviral 
transfer vector (IL). WT and p50/p52 knockout cell lines with integrated IL were stimulated with 
TNFα or LPS (B). WT and p50/p52 knockout cells integrated with the ML I1I2 transgene were 
stimulated with TNFα or LPS (C). 
 
5.  IRF-3 is recruited to the ML I1I2 transgene and required for transgene activation  
IRF-3 and IRF-3 ∆DBD were overexpressed in WT and p50/p52 deficient cells carrying the ML 
I1I2 transgene (Panels A, B respectively). IRF-3 overexpressed cells were stimulated with TNFα. 
IRF-3 was knocked-down by RNAi in p50/p52 deficient and WT cells carrying the ML I1I2 
transgene (Panels C, D respectively). IRF-3 knocked-down cells were stimulated with LPS.  
Chromatin immunoprecipitation assays with antibodies against IRF-3 demonstrate that IRF-3 is 
recruited to the IP-10 promoter but not the MCP-1promoter in a LPS-dependent manner (E, left 
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panel).  IRF-3 is recruited to the ML I1I2 transgene in a LPS-dependent manner (E, right panel). 
The white line indicates where lanes irrelevant to the figure have been cropped. 
  
6.  Induction of ML I1I2 by TNFα Requires Bcl-3 
Bcl-3 KO and Wild-type (WT) cells are stimulated with TNFα or LPS over a 4 hour time course. 
Induction of endogenous IP-10 and MCP-1 RNA transcript levels are measured by quantitative 
PCR (A). Bcl-3 KO and WT cells carrying the ML I1I2 or ML M1M2 transgene are stimulated 
with TNFα over a 4 hour time course (B). 
 
7.  Two κB sites function together to determine NF-κB family member and co-activator specificity 
 
A model depicting how two κB sites could coordinate as a single module to regulate gene 
activation. The model postulates that the two κB sites in a promoter/enhancer have separable 
functions that must be jointly provided from the module to support transcription. One is to bind 
p300/CBP, the other is to bind a second co-activator whose nature is dictated by the sequence of 
the κB site to which that NF-κB dimer is bound. One hypothetical co-activator is designated X, the 
others are known. The model is presented in the context of 4 conditions discussed in the text. In 
LPS-stimulated p50/p52 deficient cells, p65 homodimers bound to M1 and M2 recruit p300/CBP 
and X (A). In the same cells, the alteration to I1 does not allow X binding but does support IRF-3 
binding (B).  In TNFα-stimulated p50/p52 deficient cells infected with ML M1M2, the situation is 
similar to that in LPS-stimulated cells (C). However, in TNFα-stimulated p50/p52cells infected 
with ML I1I2, because IRF-3 is not activated, the p65 homodimers cannot bind a co-activator and 
gene activation does not occur (not shown).  However, in wild-type cells, NF-κB heterodimers are 
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present and p50 is able to bind Bcl-3, providing the co-activator needed for the module to function 
(D). 
 
 117
  
References 
 
Aaronson, S. A., and Todaro, G. J. (1968). Development of 3T3-like lines from Balb-c mouse 
embryo cultures: transformation susceptibility to SV40. J. Cell. Physiol. 72, 141-148. 
 
Akira, S. (2003). Toll-like receptor signaling. J. Biol. Chem. 278, 38105-38108. 
 
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., and Baltimore, D. (1995). Embryonic lethality 
and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170. 
 
Berkowitz, B., Huang, D. B., Chen-Park, F. E., Sigler, P. B., and Ghosh, G. (2002). The x-ray 
crystal structure of the NF-kappa B p50.p65 heterodimer bound to the interferon beta -kappa B 
site. J. Biol. Chem. 277, 24694-24700. 
 
Boyd, K. E., and Farnham, P. J. (1999). Coexamination of site-specific transcription factor binding 
and promoter activity in living cells. Mol. Cell. Biol. 19, 8393-8399. 
 
Boyd, K. E., Wells, J., Gutman, J., Bartley, S. M., and Farnham, P. J. (1998). c-Myc target gene 
specificity is determined by a post-DNAbinding mechanism. Proc. Natl. Acad. Sci. USA 95, 
13887-13892. 
 
Bren, G. D., Solan, N. J., Miyoshi, H., Pennington, K. N., Pobst, L. J., and Paya, C. V. (2001). 
Transcription of the RelB gene is regulated by NF-kappaB. Oncogene 20, 7722-7733. 
 
 118
  
Brown, C. T., Rust, A. G., Clarke, P. J., Pan, Z., Schilstra, M. J., De Buysscher, T., Griffin, G., 
Wold, B. J., Cameron, R. A., Davidson, E. H., and Bolouri, H. (2002). New computational 
approaches for analysis of cis-regulatory networks. Dev. Biol. 246, 86-102. 
 
Caamano, J. H., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventos-Suarez, C., Snapper, C. M., 
and Bravo, R. (1998). Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic 
microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187, 185-196. 
 
Chen, F. E., and Ghosh, G. (1999). Regulation of DNA binding by Rel/NF-kappaB transcription 
factors: structural views. Oncogene 18, 6845-6852. 
 
Chen, F. E., Huang, D. B., Chen, Y. Q., and Ghosh, G. (1998a). Crystal structure of p50/p65 
heterodimer of transcription factor NF-kappaB bound to DNA. Nature 391, 410-413. 
 
Chen, Y. Q., Ghosh, S., and Ghosh, G. (1998b). A novel DNA recognition mode by the NF-kappa 
B p65 homodimer. Nat. Struct. Biol. 5, 67-73. 
 
Chen-Park, F. E., Huang, D. B., Noro, B., Thanos, D., and Ghosh, G. (2002). The kappa B DNA 
sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV 
transcription. J. Biol. Chem. 277, 24701-24708. 
 
 119
  
Cheng, J. D., Ryseck, R. P., Attar, R. M., Dambach, D., and Bravo, R. (1998). Functional 
redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta. J. Exp. 
Med. 188, 1055-1062. 
 
Chinenov, Y., and Kerppola, T. K. (2001). Close encounters of many kinds: Fos-Jun interactions 
that mediate transcription regulatory specificity. Oncogene 20, 2438-2452. 
 
Doyle, S., Vaidya, S., O'Connell, R., Dadgostar, H., Dempsey, P., Wu, T., Rao, G., Sun, R., 
Haberland, M., Modlin, R., and Cheng, G. (2002). IRF3 mediates a TLR3/TLR4-specific antiviral 
gene program. Immunity 17, 251-263. 
 
Escalante, C. R., Shen, L., Thanos, D., and Aggarwal, A. K. (2002). Structure of NF-kappaB 
p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter. 
Structure (Camb) 10, 383-391. 
 
Falvo, J. V., Thanos, D., and Maniatis, T. (1995). Reversal of intrinsic DNA bends in the IFN beta 
gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83, 1101-
1111. 
 
Falvo, J. V., Uglialoro, A. M., Brinkman, B. M., Merika, M., Parekh, B. S., Tsai, E. Y., King, H. 
C., Morielli, A. D., Peralta, E. G., Maniatis, T., et al. (2000). Stimulus-specific assembly of 
enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol. Cell. Biol. 20, 2239-
2247. 
 120
  
 
Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K., and Siebenlist, U. (1992). 
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 
359, 339-342. 
 
 
Fujita, T., Nolan, G. P., Ghosh, S., and Baltimore, D. (1992). Independent modes of transcriptional 
activation by the p50 and p65 subunits of NF-kappa B. Genes Dev. 6, 775-787. 
 
Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., and Baltimore, D. (1993). The candidate proto-
oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 
homodimers. Genes Dev. 7, 1354-1363. 
 
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., and Grumont, R. (1999). Genetic 
approaches in mice to understand Rel/NF-kB and IkB function: trangenics and knockouts. 
Oncogene 18, 6888-6895. 
 
Ghosh, G., van Duyne, G., Ghosh, S., and Sigler, P. B. (1995). Structure of NF-kappa B p50 
homodimer bound to a kappa B site. Nature 373, 303-310. 
 
Ghosh, S., May, M. J., and Kopp, E. B. (1998). NF-kB and Rel proteins: Evolutionarily conserved 
mediators of immune responses. Annu. Rev. Immunol. 16, 225-260. 
 
 121
  
Grumont, R. J., and Gerondakis, S. (1990). Murine c-rel transcription is rapidly induced in T-cells 
and fibroblasts by mitogenic agents and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. 
Cell Growth Differ 1, 345-350. 
 
Grumont, R. J., Richardson, I. B., Gaff, C., and Gerondakis, S. (1993). rel/NF-kappa B nuclear 
complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel 
transcription in B-cells. Cell Growth Differ. 4, 731-743. 
 
Hoffmann, A., Leung, T. H., and Baltimore, D. (2003). Genetic analysis of NF-kappaB/Rel 
transcription factors defines functional specificities. Embo J. 22, 5530-5539. 
 
Hoffmann, A., Levchenko, A., Scott, M. L., and Baltimore, D. (2002). The IkB-NF-kB signaling 
module: temporal control and selective gene activation. Science 298, 1241-1245. 
 
Horwitz, B. H., Scott, M. L., Cherry, S. R., Bronson, R. T., and Baltimore, D. (1997). Failure of 
lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity 6, 765-
772. 
 
Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-
[kappa]B activity. Annu. Rev. Immunol. 18, 621-663. 
 
Karin, M., Cao, Y., Greten, F. R., and Li, Z. W. (2002). NF-kappaB in cancer: from innocent 
bystander to major culprit. Nat. Rev. Cancer 2, 301-310. 
 122
  
 
Kontgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S. 
(1995). Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral 
immunity, and interleukin-2 expression. Genes Dev. 9, 1965-1977. 
 
Kunsch, C., Ruben, S. M., and Rosen, C. A. (1992). Selection of optimal kappa B/Rel DNA-
binding motifs: interaction of both subunits of NF-kappa B with DNA is required for 
transcriptional activation. Mol. Cell. Biol. 12, 4412-4421. 
 
Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., 
Dewar, K., Doyle, M., FitzHugh, W., et al. (2001). Initial sequencing and analysis of the human 
genome. Nature 409, 860-921. 
 
Lee, G. R., Fields, P. E., Griffin, T. J., and Flavell, R. A. (2003). Regulation of the Th2 cytokine 
locus by a locus control region. Immunity 19, 145-153. 
 
Lee, T. I., Rinaldi, N. J., Robert, F., Odom, D. T., Bar-Joseph, Z., Gerber, G. K., Hannett, N. M., 
Harbison, C. T., Thompson, C. M., Simon, I., et al. (2002). Transcriptional regulatory networks in 
Saccharomyces cerevisiae. Science 298, 799-804. 
 
Lefstin, J. A., and Yamamoto, K. R. (1998). Allosteric effects of DNA on transcriptional 
regulators. Nature 392, 885-888. 
 
 123
  
Li, Z., Van Calcar, S., Qu, C., Cavenee, W. K., Zhang, M. Q., and Ren, B. (2003). A global 
transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 
100, 8164-8169. 
 
Libermann, T. A., and Baltimore, D. (1990). Activation of interleukin-6 gene expression through 
the NF-kappa B transcription factor. Mol. Cell. Biol. 10, 2327-2334. 
 
Lin, Y. S., Carey, M., Ptashne, M., and Green, M. R. (1990). How different eukaryotic 
transcriptional activators can cooperate promiscuously. Nature 345, 359-361. 
 
Liou, H. C., Sha, W. C., Scott, M. L., and Baltimore, D. (1994). Sequential induction of NF-kappa 
B/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14, 5349-5359. 
 
Lois, C., Hong, E. J., Pease, S., Brown, E. J., and Baltimore, D. (2002). Germline transmission and 
tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872. 
 
Lomvardas, S., and Thanos, D. (2002). Modifying gene expression programs by altering core 
promoter chromatin architecture. Cell 110, 261-271. 
 
Mai S., a. M. I. L. (1995). The c-myc Protein Represses the Lambda5 and Tdt Initiators. Nucleic 
Acids Research 23, 1-9. 
 
 124
  
Mechta-Grigoriou, F., Gerald, D., and Yaniv, M. (2001). The mammalian Jun proteins: 
redundancy and specificity. Oncogene 20, 2378-2389. 
 
Meffert, M. K., Chang, J. M., Wiltgen, B. J., Fanselow, M. S., and Baltimore, D. (2003). NF-kB 
Functions in Synaptic Signaling and Behavior. Nature Neuroscience. 
 
Merika, M., Williams, A. J., Chen, G., Collins, T., and Thanos, D. (1998). Recruitment of 
CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. 
Mol. Cell 1, 277-287. 
 
Morgenstern, J. P., and Land, H. (1990). A series of mammalian expression vectors and 
characterisation of their expression of a reporter gene in stably and transiently transfected cells. 
Nucleic Acids Research 18, 1068. 
 
Muller, C. W., Rey, F. A., Sodeoka, M., Verdine, G. L., and Harrison, S. C. (1995). Structure of 
the NF-kappa B p50 homodimer bound to DNA. Nature 373, 311-317. 
 
Nissen, R. M., and Yamamoto, K. R. (2000). The glucocorticoid receptor inhibits NFkappaB by 
interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. 
Genes Dev. 14, 2314-2329. 
 
Ohmori, Y., and Hamilton, T. A. (1993). Cooperative interaction between interferon (IFN) 
stimulus response element and kappa B sequence motifs controls IFN gamma- and 
 125
  
lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J. Biol. Chem. 268, 
6677-6688. 
 
Ohmori, Y., and Hamilton, T. A. (1995). The interferon-stimulated response element and a kappa 
B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-
alpha. J. Immunol. 154, 5235-5244. 
 
Pahl, H. L. (1999). Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18, 
6853-6866. 
 
Perkins, N. D., Agranoff, A. B., Pascal, E., and Nabel, G. J. (1994). An interaction between the 
DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene 
activation. Mol. Cell. Biol. 14, 6570-6583. 
 
Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., and Nabel, G. J. 
(1993). A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer 
activation. Embo J. 12, 3551-3558. 
 
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., and Nabel, G. J. (1997). 
Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. 
Science 275, 523-527. 
 
 126
  
Phillips, K., and Luisi, B. (2000). The virtuoso of versatility: POU proteins that flex to fit. J. Mol. 
Biol. 302, 1023-1039. 
 
Pierer, M., Rethage, J., Seibl, R., Lauener, R., Brentano, F., Wagner, U., Hantzschel, H., Michel, 
B. A., Gay, R. E., Gay, S., and Kyburz, D. (2004). Chemokine secretion of rheumatoid arthritis 
synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J. Immunol. 172, 1256-1265. 
 
Ping, D., Boekhoudt, G. H., Rogers, E. M., and Boss, J. M. (1999). Nuclear factor-kappa B p65 
mediates the assembly and activation of the TNF-responsive element of the murine monocyte 
chemoattractant-1 gene. J. Immunol. 162, 727-734. 
 
Pomerantz, J. L., and Baltimore, D. (1999). NF-kappaB activation by a signaling complex 
containing TRAF2, TANK and TBK1, a novel IKK-related kinase. Embo J. 18, 6694-6704. 
 
Qin, X. F., An, D. S., Chen, I. S., and Baltimore, D. (2003). Inhibiting HIV-1 infection in human T 
cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. 
USA 100, 183-188. 
 
Ramji, D. P., and Foka, P. (2002). CCAAT/enhancer-binding proteins: structure, function and 
regulation. Biochem. J. 365, 561-575. 
 
Rastinejad, F. (2001). Retinoid X receptor and its partners in the nuclear receptor family. Curr. 
Opin. Struct. Biol. 11, 33-38. 
 127
  
 
Re, F., and Strominger, J. L. (2001). Toll-like receptor 2 (TLR2) and TLR4 differentially activate 
human dendritic cells. J. Biol. Chem. 276, 37692-37699. 
 
Rogatsky, I., Luecke, H. F., Leitman, D. C., and Yamamoto, K. R. (2002). Alternate surfaces of 
transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and 
repression contexts. Proc. Natl. Acad. Sci. USA 99, 16701-16706. 
 
Rogatsky, I., Wang, J. C., Derynck, M. K., Nonaka, D. F., Khodabakhsh, D. B., Haqq, C. M., 
Darimont, B. D., Garabedian, M. J., and Yamamoto, K. R. (2003). Target-specific utilization of 
transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 100, 
13845-13850. 
 
Rothenberg, E. V., and Ward, S. B. (1996). A dynamic assembly of diverse transcription factors 
integrates activation and cell-type information for interleukin 2 gene regulation. Proc. Natl. Acad. 
Sci. USA 93, 9358-9365. 
 
Saccani, S., Pantano, S., and Natoli, G. (2001). Two waves of nuclear factor kappaB recruitment to 
target promoters. J. Exp. Med. 193, 1351-1359. 
 
Saccani, S., Pantano, S., and Natoli, G. (2003). Modulation of NF-kappaB activity by exchange of 
dimers. Mol. Cell 11, 1563-1574. 
 
 128
  
Sakaguchi, S., Negishi, H., Asagiri, M., Nakajima, C., Mizutani, T., Takaoka, A., Honda, K., and 
Taniguchi, T. (2003). Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene 
expression and endotoxin shock. Biochem. Biophys. Res. Commun. 306, 860-866. 
 
Sanjabi, S., Hoffmann, A., Liou, H. C., Baltimore, D., and Smale, S. T. (2000). Selective 
requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. 
USA 97, 12705-12710. 
 
Scott, M. L., Fujita, T., Liou, H. C., Nolan, G. P., and Baltimore, D. (1993). The p65 subunit of 
NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 7, 1266-1276. 
 
Serbina, N. V., Kuziel, W., Flavell, R., Akira, S., Rollins, B., and Pamer, E. G. (2003). Sequential 
MyD88-independent and -dependent activation of innate immune responses to intracellular 
bacterial infection. Immunity 19, 891-901. 
 
Sha, W. C., Liou, H. C., Tuomanen, E. I., and Baltimore, D. (1995). Targeted disruption of the p50 
subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80, 321-330. 
 
Sheppard, K. A., Rose, D. W., Haque, Z. K., Kurokawa, R., McInerney, E., Westin, S., Thanos, D., 
Rosenfeld, M. G., Glass, C. K., and Collins, T. (1999). Transcriptional activation by NF-kappaB 
requires multiple coactivators. Mol. Cell. Biol. 19, 6367-6378. 
 
Takeda, K., Kaisho, T., and Akira, S. (2003). Toll-like receptors. Annu Rev Immunol 21, 335-376. 
 129
  
Thanos, D., and Maniatis, T. (1995a). Identification of the rel family members required for virus 
induction of the human beta interferon gene. Mol. Cell. Biol. 15, 152-164. 
 
Thanos, D., and Maniatis, T. (1995b). Virus induction of human IFN beta gene expression requires 
the assembly of an enhanceosome. Cell 83, 1091-1100. 
 
Trimarchi, J. M., and Lees, J. A. (2002). Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. 
Biol. 3, 11-20. 
 
Weinmann, A. S., Yan, P. S., Oberley, M. J., Huang, T. H., and Farnham, P. J. (2002). Isolating 
human transcription factor targets by coupling chromatin immunoprecipitation and CpG island 
microarray analysis. Genes Dev. 16, 235-244. 
 
Wietek, C., Miggin, S. M., Jefferies, C. A., and O'Neill, L. A. (2003). Interferon regulatory factor-
3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 
but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278, 50923-50931. 
 
Wolfe, S. A., Nekludova, L., and Pabo, C. O. (2000). DNA recognition by Cys2His2 zinc finger 
proteins. Annu. Rev. Biophys. Biomol. Struct. 29, 183-212. 
 
Xu, Y., Davidson, L., Alt, F. W., and Baltimore, D. (1996). Deletion of the Ig kappa light chain 
intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa 
rearrangement. Immunity 4, 377-385. 
 130
  
 
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, 
M., Okabe, M., Takeda, K., and Akira, S. (2003). Role of adaptor TRIF in the MyD88-independent 
toll-like receptor signaling pathway. Science 301, 640-643. 
 
Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, 
O., Kobayashi, M., Fujita, T., et al. (2002). Essential role for TIRAP in activation of the signalling 
cascade shared by TLR2 and TLR4. Nature 420, 324-329. 
 
 
 
 131
  
 132
MouseGene Human
Fas GGGAATGCCC GGGAATGCCC
MCP-1 GGGAACTTCC GGGAACTTCC GGGAATTTCC GGGAATTTCC
RANTES GGGAGTTTCC GGGAGTTTCC
IP-10 GGGAAATTCC GGGAAATTCCGGGACTTCCC GGGACTTCCC
JunB GGGGCTTTCC GGGGCTTTCC
MIP2 GGGAATTTCC GGGAATTTCC
LIF GGGGATCCCG GGGGATCCCG
IFN§ GGGAAATTCC GGGAAATTCC
IL-6 GGATTTTCCC GGATTTTCCC
M-CSF GGAAAGTCCC GGAAAGTCCC
I B GGAAATTCCC GGAAATTCCCGGGGAAGTCC GGGGAAGTCC
A.
B.
1
5
9
13
0 1 2 3 4 5 hrs
p50/p65 KO
wt
C.
1
4
7
10
13
0 1 2 3 4 5
wt M1M2
wt N1N2
hrs
1
4
7
10
13
0 1 2 3 4 5 hrs
wt M1M2
wt M1N2
1
4
7
10
13
0 1 2 3 4 5
wt N1M2
wt M1M2
hrs
M1 M2
In
du
ct
io
n 
Fo
ld
N1 N2
M1 N2 N1 M2
In
du
ct
io
n 
Fo
ld
D.
  
M1 M2
GGGAACTTCCMCP-1 GGGAATTTCC
GGGAAATTCCMCP-1 GGGACTTCCC
I1 I2
A.
1
4
7
10
13
0 1 2 3 4 5
p50/p52 KO
In
du
ct
io
n 
Fo
ld
wt
hrs
1
4
7
10
13
0 1 2 3 4 5
wt
p50/p52 KO
hrs
1
6
11
16
0 1 2 3 4 5
I1 I1C.
wt
p50/p52 KO
In
du
ct
io
n 
Fo
ld
hrs
1
4
7
10
0 1 2 3 4 5
wt
p50/p52 KO
hrs
I2 I2
1
4
7
10
0 1 2 3 4 5
B.
wt
p50/p52 KO
In
du
ct
io
n 
Fo
ld
hrs
M1 I2
1
4
7
10
0 1 2 3 4 5
wt
p50/p52 KO
hrs
I1 M2
I1 I2M1 M2
 
 133
  
 134
A. wt I1I2 p50/p52 KO I1I2
- 4 4 42-
-p65 + + + + +
TNF
+
2
B.
IP-10
MCP-1
C.
-p300
p50/p52 KO 
I1I2
- 4 4TNF
+ + -
I1I2
D.
IP-10
MCP-1
4 4
+ --p300
TNF
+
-
p50/p52 KO 
M1M2
-p65
- 4 4TNF
+ + -
p50/p52 KO
-
 
  
1
3
5
7
0 2 4 6
wt
p50/p52 KO
hrs
1
4
7
10
0 2 4 6
In
du
ct
io
n 
Fo
ld
B. IP-10 Transgene
TNF LPS
wt
p50/p52 KO
hrs
1
4
7
10
13
0 1 2 3 4 5
1
3
5
7
0 2 4 6
C.
In
du
ct
io
n 
Fo
ld TNF
wt
p50/p52 KO
wt
p50/p52 KO
LPS
hrshrs
I1 I2
0
75
150
225
0 2 4 6
0
75
150
225
0 1 2 3 4 5
A. Endogenous IP-10 Transcript
In
du
ct
io
n 
Fo
ld TNF LPSwt
p50/p52 KO wt
p50/p52 KO
1 1
hrs hrs
 
 135
  
 136
1
3
5
7
9
0 1 2 3 4
1
3
5
7
9
0 2 4 6
A.
B.
D.
IRF-3 RNAi
IRF-3 RNAi
In
du
ct
io
n 
Fo
ld
In
du
ct
io
n 
Fo
ld
C.
IRF-3
actin
+ +
5052wt
- -
+
wt
-
+
5052
-
actin
actin
1
3
5
7
9
0 2 4 6
+IRF3
wt
p50/p52 KO
In
du
ct
io
n 
Fo
ld
hrs
TNF
1
3
5
7
9
0 2 4 6
p50/p52 KO
wt
In
du
ct
io
n 
Fo
ld
hrs
+ IRF-3 ÌDBD
TNF
LPS
LPS
5052
+RNAi
+RNAi
wt
hrs
hrs
IRF-3 ÌDBD +
wt
- +
5052
-
actin
0 2 4 4LPS
-IRF-3 + + + -
wt IRF-3
IP-10
MCP-1
E.
I1I2
0 2 4 4LPS
-IRF-3 + + + -
wt I1I2 IRF-3
  
 137
0
20
40
60
0 1 2 3 4 5
0
75
150
225
0 1 2 3 4 5
IP-10
wt
bcl-3 KO
MCP-1
A.
bcl-3 KO
wt
hrs
In
du
ct
io
n 
Fo
ld
11
hrs
1
5
9
13
0 1 2 3 4 5
1
5
9
13
0 1 2 3 4 5
B.
In
du
ct
io
n 
Fo
ld
hrs
wt wt
bcl-3 KO
bcl-3 KO
hrs
ML I1I2 ML M1M2
 
  
LP
S 
St
im
ul
at
io
n
M
1
65
p3
00
/C
B
P
R
N
A
 P
ol
 II
M
26
5
65
65 I1
65
p3
00
/C
B
P
R
N
A
 P
ol
 II
I2
65
65
65
IR
F-
3
LP
S 
St
im
ul
at
io
n
TN
F 
St
im
ul
at
io
n
M
1
65
p3
00
/C
B
P
R
N
A
 P
ol
 II
M
26
5
65
65 I1
65
p3
00
/C
B
P
R
N
A
 P
ol
 II
I2
50
65
50
B
cl
-3
TN
F 
St
im
ul
at
io
n
A
. B
.
C
.
D
.
X
X
 
 138
  
CHAPTER 5: FUTURE STUDIES 
There are two major directions for future work in the lab.  1.  To understand how universal is this 
mechanism of regulation?  2.  To extend our studies and use biochemical and biophysical methods 
to understand mechanistically how the κB site sequence determines co-activator requirements. 
 
Aim 1.  Global mechanism studies 
We would like to understand if κB family member and co-activator requirements generated by the 
κB site sequence remain the same across different cell types and promoters.  We postulate that the 
κB site may place bound κB dimer(s) in a particular conformation that interacts most favorable 
with other important control elements for a particular promoter.  Evolution would ensure that 
preferred sequences are promoted and conserved. If this hypothesis holds true, the sequence of the 
κB site may predict potential interaction partners between NF-κB and other co-
activators/transcription factors.  For example, the κB site sequences found in the IP-10 promoter 
may position bound κB dimers to interact favorably with IRF-3 or Bcl-3.  We could then catalog 
potential interaction partners for each κB site sequence.  Ultimately, this information would help 
decipher the promoter code and gene regulatory networks. 
 
Some questions to address are: 
1.  Are gene promoter requirements for specific κB family members and co-activators the same 
across different cell types? 
 
2.  Our c-fos minimum promoter experiments suggested that κB family members requirements are 
intrinsic to the κB site sequence and cryptic sites were not responsible for this behavior.  Do genes 
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that have the exact same κB site sequences respond in similar fashions?  Our IP-10 κB site 
sequences are an ideal starting point for a genome analysis. The presence of other transcription 
factor binding sites on the “identified” genes may or may not affect gene regulation.  Either way, it 
will be interesting to see if different patterns or consistencies among genes with identical κB 
binding site sequences can be formed.   
 
3.  Do other dual κB-binding site containing genes behave in a similar way?  Our system is easily 
amendable to the study of other promoters.  The more examples we can test, the better we will 
understand what is going on.   
 
4.  Do single κB-binding site containing promoters behave in a similar manner?  A single site may 
reduce the complexity of the promoter code and allow for easier dissection of potential.  
 
5.  Do other transcription factor families behave in a similar way?  As mentioned above, outside 
the NHR family, little is know about how other eukaryotic transcription factor families determine 
specificity.  Other families are similarly set-up to NF-κB (i.e. many family members recognize the 
same binding sites), and this mechanism may answer why marked DNA-binding specificity rules 
have not been identified. 
 
Aim 2: Biochemical and Biophysical Studies 
 
1.  What is factor X?  Previously, we showed that MCP-1 κB sites are capable of promoting gene 
expression without Bcl-3 or IRF-3 co-activators and the presence of either MCP-1 κB site is 
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capable of bypassing the Bcl-3 requirement.  In our model, we proposed that each κB site serves a 
specific non-redundant function and suggest that either MCP-1 κB site is capable of recruiting 
factor “X”, a co-activator needed for gene activation. 
 
2.  Characterization of the interactions between p50:p65 heterodimers and its new co-activators, 
Bcl-3 and IRF-3.  While our results have established their interactions as a physiologically relevant 
control mechanism, we lack detailed information regarding their interactions, which may or may 
not involve another cofactor or meditating protein.   
 
3.  Biophysical studies to address whether the conformation of bound NF-κB dimers directly 
determines co-activator requirements via Biacore technology and crystal structures. 
Significant conformational differences are expected between p50:p65 heterodimers bound to 
M1M2 and I1I2 that will prove that the sequence of the κB site affects the conformation of the 
bound dimer.  If the structure of p50:p65 heterodimers bound to M1M2 and I1I2 are solved, the 
analysis should be extended, and an attempt to solve a structure with p50:p65 heterodimers bound 
to M1M2 or I1I2 and their appropriate co-activators will be made. 
 
Concluding Remarks 
The field of gene regulation has had a seemingly natural progression.  The field started with 
bacteria and has now progressed to study higher eukaryotes.  By steadily increasing genome sizes, 
some of the original concepts have also increased in complexity.  In bacteria, we began with two 
molecules whose binding sites were close to the transcription start site.  In larger genomes, we 
discovered that binding sites could be moved farther away.  Finally in higher eukaryotes, the model 
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promoter of gene regulation has (at least) four different transcription factor families interacting for 
gene activation to occur.  My work has built on this foundation and addressed a long-standing 
question in the field, how do individual members in a particular transcription factor family function 
on a given gene promoter.    
 
Other concepts of gene regulation have remained the same but presented in a different flavor.  In 
bacteria, allostery between allolactase and repressor controlled gene activation.  My work 
identified a situation where DNA may act as an allosteric regulator of NF-κB to determine gene 
activation.  Instead of a protein-protein allosteric interaction, we are characterizing a DNA-protein 
allosteric interaction.  I’m still a ways away from proving this to be empirically true, but as Monod 
said: “There is in science, however, quite a gap between belief and certainty.  But would one ever 
have patience to wait and to establish the certainty if the inner conviction were not already there?” 
 
While I am trying to establish certainty, I still have much to learn from bacterial gene regulation.  
Two recent findings, one for lacZ and one for lambda repressor, illustrates this best and may have 
important implications for the control of NF-κB.  As described above, crystal structures recently 
demonstrated that the sequence of DNA determines the conformation of bound lac-Repressor and 
affects lac-Repressor’s function.  Depending on the sequence of DNA, the DNA-binding domain 
of repressor can actually adopt two strikingly different conformations.  We postulate that this 
phenomenon applies to NF-κB.  Also, oligomerization of the lambda repressor was shown to be a 
significant and biological relevant mechanism of regulation for the lambda switch.  As described 
above, we find this to be an attractive hypothesis for regulation in the NF-κB family as well.   
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All in all, this is an exciting time to be in the field of gene regulation. 
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